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A FALSE START IN THE RACE AGAINST
DOPING IN SPORT: CONCERNS WITH
CYCLING’S BIOLOGICAL PASSPORT
NICHOLAS HAILEY †
The biological passport is . . . . like a custom-built Ferrari: but maybe
it’s been put on the road too soon to act as an anti-doping control.
1
– Dr. Roberto Corsetti

ABSTRACT
Professional cycling has suffered from a number of doping
scandals. The sport’s governing bodies have responded by
implementing an aggressive new antidoping program known as the
biological passport. Cycling’s biological passport marks a departure
from traditional antidoping efforts, which have focused on directly
detecting prohibited substances in a cyclist’s system. Instead, the
biological passport tracks biological variables in a cyclist’s blood and
urine over time, monitoring for fluctuations that are thought to
indirectly reveal the effects of doping. Although this method of
indirect detection is promising, it also raises serious legal and
scientific concerns. Since its introduction, the cycling community has
debated the reliability of indirect biological-passport evidence and the
clarity, consistency, and transparency of its use in proving doping
violations. Such uncertainty undermines the legitimacy of finding
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cyclists guilty of doping based on this indirect evidence alone.
Antidoping authorities should address these important concerns
before continuing to pursue doping sanctions against cyclists solely on
the basis of their biological passports.

INTRODUCTION
2

3

Doping is as old as the sport of cycling itself. As early as the
nineteenth century, cyclists competing in the grueling “six-day” races
concocted cocktails of caffeine, strychnine, and cocaine to improve
4
their performance. In the years since, long-distance cycling has
become known as “the most consistently drug-soaked sport of the
5
twentieth century.”
6
In October 2007, the International Cycling Union (UCI) and
7
World Anti-Doping Agency (WADA) agreed to implement a radical

2. For the purposes of this Note, the term “doping” will be used to refer generally to the
use of any prohibited substance or method to improve athletic performance. Similarly, the
World Anti-Doping Code (Code) defines doping broadly as “the occurrence of one or more of
the anti-doping rule violations” described in the Code. WORLD ANTI-DOPING AGENCY,
WORLD ANTI-DOPING CODE 18 (2009), available at http://www.wada-ama.org/rtecontent/
document/code_v2009_EN.pdf. These doping violations include having of a prohibited
substance in an athlete’s blood or urine, using or attempting to use a prohibited substance or
method, refusing to submit to or missing doping tests, tampering with doping-test samples,
possessing or trafficking in a prohibited substance or method, or administering a prohibited
substance or method to another athlete. Id. at 19–25. The Prohibited List details the various
prohibited substances and methods defined as doping under the Code. Id. at 29.
3. In fact, the history of doping in sport dates back thousands of years. The ancient
Greeks experimented with the performance-enhancing effects of dried figs as early as the
Olympic Games of 668 B.C. They also experimented with the stimulant effects of brandy and
wine and even reportedly ate animal and human testes to boost their testosterone levels.
Richard I.G. Holt, Ioulietta Erotokritou-Mulligan & Peter H. Sönksen, The History of Doping
and Growth Hormone Abuse in Sport, 19 GROWTH HORMONE & IGF RES. 320, 320 (2009); see
also A Brief History of Anti-Doping, WORLD ANTI-DOPING AGENCY, http://www.wadaama.org/en/About-WADA/History/A-Brief-History-of-Anti-Doping (last updated June 2010)
(providing a historical account of doping practices).
4. Holt et al., supra note 3, at 321.
5. John Hoberman, How Drug Testing Fails: The Politics of Doping Control, in DOPING
IN ELITE SPORT: THE POLITICS OF DRUGS IN THE OLYMPIC MOVEMENT 241, 264 (Wayne
Wilson & Edward Derse eds., 2001).
6. The UCI is the international federation (IF) that governs the sport of professional
cycling. Mission Statement, UNION CYCLISTE INTERNATIONALE, http://www.uci.ch/templates/
UCI/UCI1/layout.asp?MenuId=MTI2NjA&LangId=1 (last visited Oct. 7, 2011).
7. WADA is the international organization that governs antidoping efforts across all
Olympic sports, including professional cycling. About WADA, WORLD ANTI-DOPING AGENCY,
http://www.wada-ama.org/en/About-WADA (last updated June 2011).
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new antidoping program known as the biological passport. This
decision came in the wake of an extraordinary succession of doping
9
10
scandals surrounding the 2007 Tour de France —a “doping crisis”
that rocked professional cycling and threatened the sport’s
11
credibility.
Cycling’s biological passport represents an aggressive new
approach to antidoping efforts in sport. The biological passport is an
12
that collates various biological
individual, electronic profile
13
parameters in a cyclist’s blood and urine. Whereas antidoping
efforts have traditionally focused on the direct detection of prohibited
14
substances in a cyclist’s blood or urine, the biological passport

8. Juliet Macur, Cycling Union Takes Leap in Fight Against Doping, N.Y. TIMES, Oct. 24,
2007, at D5 (calling the biological passport “a monumental step for cycling”).
9. At the 2007 Tour, prerace favorite Alexander Vinokourov tested positive for illegal
blood doping and was banned from the sport for two years. Edward Wyatt, Tour Is Hit with
Another Blow as a Favorite Fails a Drug Test, N.Y. TIMES, July 25, 2007, at D1 [hereinafter
Wyatt, Tour Is Hit]. Following Vinokourov’s positive doping test, his entire Astana team
withdrew from the race. Id. Subsequently, the Tour’s overall leader, Michael Rasmussen, was
expelled from the race for lying about his whereabouts to evade prerace doping tests. Edward
Wyatt, Tour in Tatters: Race Leader Ousted by His Team, N.Y. TIMES, July 26, 2007, at A1.
Finally, more than a year after winning the 2006 Tour de France, Floyd Landis was
ignominiously stripped of his Tour crown after the U.S. Anti-Doping Agency (USADA) upheld
his positive test for prohibited synthetic-testosterone use during that race. Juliet Macur, Landis
Loses His Case and Title, N.Y. TIMES, Sept. 21, 2007, at D1 (noting that Landis was “the first
champion in the history of the [Tour de France] to lose the title because of a doping offense”).
10. Wyatt, Tour Is Hit, supra note 9.
11. See Juliet Macur, As Scandals Arose, Armstrong Just Rode On, N.Y. TIMES, Jan. 2,
2010, at D7 (“[T]he race [was] a pharmacological feat, not a physical one. The sport’s credibility
was crumbling.”); John Leicester, Cycling—and Tour de France—Mired in Scandal, Having
Failed To Learn from Past, ASSOCIATED PRESS, July 26, 2007, available at Factiva, Doc. No.
APRS000020070727e37r009vp (“An optimist—and there aren’t many left in cycling—would say
that the only advantage for the scandal-mired sport is that things can’t get much worse.”).
12. For an illustration of a biological-passport profile, see UNION CYCLISTE
INTERNATIONALE, THE BIOLOGICAL PASSPORT AND THE UCI’S ANTI-DOPING MEASURES 17–
18 (2008), available at http://www.uci.ch/Modules/BUILTIN/getObject.asp?MenuId=MjI0NQ&
ObjTypeCode=FILE&type=FILE&id=NDY4MjA&LangId=1.
13. The biological variables monitored include hemoglobin, reticulocytes, and hematocrit.
Michael Wozny, The Biological Passport and Doping in Athletics, 376 LANCET 79, 79 (2010);
Biological Passport—Questions/Answers, UNION CYCLISTE INTERNATIONALE, http://www.
uci.ch/templates/UCI/UCI2/layout.asp?MenuId=MTU4ODY&LangId=1 (last updated Feb. 9,
2011).
14. Richard H. McLaren, CAS Doping Jurisprudence: What Can We Learn?, 2006 INT’L
SPORTS L. REV. 4, 9 (2006) (“[D]oping offences are usually established by direct evidence,
where a positive drug test will directly show that an athlete had a prohibited substance in [his]
body . . . .”). This statement is somewhat of an oversimplification. See infra note 113.
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instead tracks fluctuations in otherwise-normal biological variables
15
that are thought to indirectly reveal the effects of doping.
In other words, cycling’s biological passport does not require a
cyclist to actually test positive for a prohibited substance or method—
a result known as an analytical positive finding—before being found
16
guilty of doping. Instead, cyclists can be prosecuted, found guilty,
and sanctioned for doping based solely on inferences drawn from
biological fluctuations.
Although the Court of Arbitration for Sport (CAS) has upheld
the initial doping sanctions that have arisen under cycling’s biological
passport, this Note argues that serious concerns remain regarding the
reliability of inferences drawn from biological-passport data and
regarding the fairness of sanctioning cyclists for doping solely on the
basis of this indirect evidence. As a result, the program’s approach
fails to strike the proper balance between effectively policing the
17
sport for doping and safeguarding cyclists’ individual rights.
Accordingly, until the science underlying cycling’s biological passport
has been further refined, cyclists should not be found guilty of doping
violations unless additional corroborating evidence of doping exists.
Part I of this Note provides an overview of the antidoping
framework in international sport, describing the numerous
international and national organizations that manage and administer
antidoping policy. Part II describes the shifting focus of antidoping
efforts, from traditional approaches premised on direct detection of
doping to more recent efforts that rely increasingly on indirect
detection. Part III discusses the introduction of cycling’s biological
passport and the first antidoping cases pursued under the program.
15. See Athlete Biological Passport, WORLD ANTI-DOPING AGENCY, http://www.wadaama.org/en/Science-Medicine/Athlete-Biological-Passport (last updated Dec. 2009) (“The
fundamental principle of the [biological passport] is based on the monitoring of an athlete’s
biological variables over time to facilitate indirect detection of doping on a longitudinal basis,
rather than on the traditional direct detection of doping.”); Biological Passport—
Questions/Answers, supra note 13 (“The approach relies on the concept of ‘indirect’ detection.
Scientific experts will not actually ‘see’ a banned substance in a sample. Instead, they will
compare the parameters of the new sample to parameters measured in previous samples. In this
way, fluctuations in the riders’ levels which may indicate manipulation can be identified.”).
16. McLaren, supra note 14, at 9.
17. See Ryan Connolly, Note, Balancing the Justices in Anti-Doping Law: The Need To
Ensure Fair Athletic Competition Through Effective Anti-Doping Programs Vs. the Protection of
Rights of Accused Athletes, 5 VA. SPORTS & ENT. L.J. 161, 174 (2006) (“The complex nature of
anti-doping efforts requires a carefully crafted legal system to accomplish the dual goals of
ensuring fair sport through effective anti-doping measures and assuring equity to individual
athletes.”).
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Part IV evaluates the unique concerns raised by the biological
passport, specifically the reliability of indirect biological-passport
evidence and the fairness of finding cyclists guilty of doping based on
this evidence alone. Part V provides recommendations that would
allow antidoping authorities to address these concerns while
continuing to utilize the biological passport as an antidoping control.
I. THE ANTIDOPING MOVEMENT IN INTERNATIONAL SPORT
International antidoping efforts are governed by private
18
contracts and administered by a network of international and
19
national organizations. Antidoping regulation in international sport
20
is essentially “the enforcement of these private agreements.”
Numerous antidoping authorities enforce these regulations, including
the International Olympic Committee (IOC), WADA, international
federations (IFs), national governing bodies (NGBs), and the CAS.
To enter into international competition, athletes must agree to be
21
bound by the antidoping rules that govern their respective sports.
For instance, professional cyclists agree to submit to in- and out-of22
competition doping tests and to abide by sanctions if they are found
23
guilty of doping violations.
A. The IOC
Antidoping efforts in international sport have traditionally been
24
focused on the Olympic Movement. The IOC is the “supreme
authority of the Olympic Movement” and has ultimate control over

18. Michael Straubel, Enhancing the Performance of the Doping Court: How the Court of
Arbitration for Sport Can Do Its Job Better, 36 LOY. U. CHI. L.J. 1203, 1259 (2005); Connolly,
supra note 17, at 174.
19. Connolly, supra note 17, at 163.
20. Id. at 175.
21. UNION CYCLISTE INTERNATIONALE, UCI CYCLING REGULATIONS: PART 14: ANTIDOPING (2011), available at http://www.uci.ch/Modules/BUILTIN/getObject.asp?MenuId=&
ObjTypeCode=FILE&type=FILE&id=NDc3MDk (“Riders and other Persons accept these
rules as a condition of participation and shall be bound by them.”); WORLD ANTI-DOPING
AGENCY, supra note 2, at 17 (“Athletes or other Persons accept these rules as a condition of
participation and shall be bound by these rules.” (emphasis omitted)).
22. See, e.g., UNION CYCLISTE INTERNATIONALE, supra note 21, at 1–3 (outlining the
parameters of these tests).
23. See, e.g., id. at 51–62 (describing the sanctions and consequences for doping violations).
24. Connolly, supra note 17, at 163.

HAILEY IN FR

398

10/13/2011 9:50:35 AM

DUKE LAW JOURNAL

[Vol. 61:393

25

antidoping regulation in all Olympic sports. To be eligible for the
Olympic Games, all IFs, national Olympic committees (NOCs), and
26
NGBs must adhere to the IOC’s rules. The IOC created WADA
and the CAS and designated them as the independent bodies
responsible for administering antidoping efforts.
B. WADA and the World Anti-Doping Code
WADA is the international organization that governs antidoping
27
efforts across all Olympic sports, including professional cycling.
WADA was born in the aftermath of the Festina affair, a major
scandal at the 1998 Tour de France that revealed a widespread
28
network of systematic doping in professional cycling. The Festina
affair underscored the need for an independent body to govern
29
antidoping efforts in international sport. As a result, the IOC
30
founded WADA the following year.
WADA “promote[s], coordinate[s], and monitor[s] the fight
31
against doping in sport in all its forms.” WADA serves a twofold
purpose: (1) to protect the fundamental rights of athletes to
participate in sport free of doping and “thus promote health, fairness
and equality” for athletes worldwide, and (2) to “ensure harmonized,
coordinated and effective antidoping programs at the international
and national level with regard to detection, deterrence and
32
prevention of doping.” To meet these goals, WADA administers the
33
World Anti-Doping Program, which comprises the World Anti25. INT’L OLYMPIC COMM., ANTI-DOPING RULES APPLICABLE TO THE GAMES OF THE
XXIX OLYMPIAD, BEIJING 2008, at 3 (2008), available at http://www.olympic.org/Documents/
Reports/EN/en_report_1316.pdf.
26. See, e.g., INT’L OLYMPIC COMM., OLYMPIC CHARTER 25 (2011), available at http://
www.olympic.org/Documents/olympic_charter_en.pdf (“The statutes, practice and activities of
the IFs within the Olympic Movement must be in conformity with the Olympic Charter,
including the adoption and implementation of the World Anti-Doping Code.”).
27. About WADA, supra note 7.
28. See generally Samuel Abt, Tour de France Faces Its Worst Crisis, N.Y. TIMES, July 30,
1998, at C1 (detailing the controversy over drug testing during the 1998 Tour de France).
29. A Brief History of Anti-Doping, supra note 3.
30. Id.
31. Frequently Asked Questions, WORLD ANTI-DOPING AGENCY, http://www.wada-ama
.org/en/Footer-Links/FAQ (last updated Apr. 2010).
32. WORLD ANTI-DOPING AGENCY, supra note 2, at 11.
33. See World Anti-Doping Program, WORLD ANTI-DOPING AGENCY, http://www.wadaama.org/en/World-Anti-Doping-Program (last updated Oct. 2010) (“The World Anti-Doping
Program was developed and implemented to harmonize anti-doping policies and regulations
within sport organizations and among governments.”).
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Doping Code (Code), International Standards, and Model Rules
36
and Guidelines.
The Code is the uniform set of antidoping rules that governs all
37
Olympic sports, including professional cycling. The Code formally
38
defines doping and describes the burden of proof, standard of proof,
39
40
evidentiary standards, and right to a fair hearing applicable to all
disciplinary proceedings for doping violations. The Olympic Charter
requires that all organizations within the Olympic Movement adopt
41
and implement the Code.

34. WORLD ANTI-DOPING AGENCY, supra note 2.
35. See International Standards, WORLD ANTI-DOPING AGENCY, http://www.wadaama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/InternationalStandards (last updated Oct. 2009) (“The [Code]. works in conjunction with five International
Standards aimed at bringing harmonization among anti-doping organizations in various
technical areas.”). The International Standards include the Prohibited List, WORLD ANTIDOPING AGENCY, THE 2011 PROHIBITED LIST (2010) [hereinafter WORLD ANTI-DOPING
AGENCY, THE 2011 PROHIBITED LIST], available at http://www.wada-ama.org/Documents/
World_Anti-Doping_Program/WADP-Prohibited-list/To_be_effective/WADA_Prohibited_
List_2011_EN.pdf, which details the various prohibited substances and methods defined as
doping under the Code. WORLD ANTI-DOPING AGENCY, supra note 2, at 29–36.
36. See Model Rules & Guidelines, WORLD ANTI-DOPING AGENCY (May 2010), http://
www.wada-ama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/
Model-Rules--Guidelines (“Model Rules, guidelines and protocols provide recommended
solutions to stakeholders in different areas of anti-doping.”).
37. See World Anti-Doping Code, WORLD ANTI-DOPING AGENCY, http://www.wadaama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/The-Code
(last updated May 2011) (“The Code is the core document that provides the framework for
harmonized anti-doping policies, rules and regulations within sport organizations and among
public authorities.”).
38. WORLD ANTI-DOPING AGENCY, supra note 2, at 18.
39. Id. at 26–28.
40. Id. at 48.
41. See supra note 26. To date, the Code has been formally adopted by all 26 IFs that
participate in the Summer Olympics, all 7 IFs that participate in the Winter Olympics, 34 IFs
that do not compete in the Olympics but are recognized by the IOC, Code Acceptance: List of
International Federations, WORLD ANTI-DOPING AGENCY, http://www.wada-ama.org/en/AntiDoping-Community/IFs/List-of-IFs (last updated Jan. 2009), all 205 NOCs, Code Acceptance:
Olympic Movement, WORLD ANTI-DOPING AGENCY, http://www.wada-ama.org/en/WorldAnti-Doping-Program/Sports-and-Anti-Doping-Organizations/The-Code/Code-Acceptance/
Olympic-Movement (last updated Aug. 2011), and 130 national antidoping organizations, Code
Acceptance: Government-Funded Organizations, WORLD ANTI-DOPING AGENCY, http://www.
wada-ama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/TheCode/Code-Acceptance/Government-funded-Organizations (last updated Dec. 2009), as well as
by a number of other organizations, Code Acceptance: Outside the Olympic Movement, WORLD
ANTI-DOPING AGENCY, http://www.wada-ama.org/en/World-Anti-Doping-Program/Sportsand-Anti-Doping-Organizations/The-Code/Code-Acceptance/Outside-the-Olympic-Movement
(last updated July 2011).
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C. IFs
42

IFs govern particular sports at the international level and
43
administer international antidoping programs. In this capacity, IFs
initiate disciplinary proceedings for alleged doping violations and act
44
as the prosecuting authority in these cases. The UCI is the IF that
45
governs the sport of cycling and the body that directly administers
46
cycling’s biological passport. The UCI has incorporated the Code
47
into its own antidoping rules, formally placing antidoping efforts in
48
professional cycling under WADA’s ultimate authority.
D. NGBs
49

NGBs manage their respective sports at the national level. Each
NGB is a member of its sport’s IF and must adhere to the IF’s
50
antidoping rules and to the Code. NGBs in professional cycling
include the Italian Cycling Federation (FCI) and the Royal Spanish
Cycling Federation (RFEC). These bodies adjudicate disciplinary
51
proceedings in which the UCI accuses cyclists of doping violations.
These proceedings are governed by the UCI’s antidoping rules and by
52
the Code.
E. The CAS
The CAS is international sport’s highest court and the “exclusive
arbitral tribunal for the binding adjudication of disputes” involving

42. Connolly, supra note 17, at 163.
43. Maureen A. Weston, Doping Control, Mandatory Arbitration, and Process Dangers for
Accused Athletes in International Sports, 10 PEPP. DISP. RESOL. L.J. 5, 13 (2009).
44. Id. at 30.
45. Mission Statement, supra note 6.
46. UCI Anti-Doping Programme, UNION CYCLISTE INTERNATIONALE, http://www.uci.ch/
templates/UCI/UCI1/layout.asp?MenuId=MTUzNDc&LangId=1 (last visited Oct. 7, 2011).
47. See UNION CYCLISTE INTERNATIONALE, supra note 21 (“[T]he UCI Management
Committee decided to accept the World Anti-Doping Code and to incorporate the Code in
UCI’s Regulations . . . .”).
48. Press Release, World Anti-Doping Agency, UCI Adopts Code (July 23, 2004),
available at http://www.wada-ama.org/en/News-Center/Articles/UCI-Adopts-Code.
49. Connolly, supra note 17, at 163.
50. Id.
51. See UNION CYCLISTE INTERNATIONALE, supra note 21, at 46 (delineating the right to a
fair hearing). NGBs may also choose to refer antidoping cases to an external hearing panel, such
as an NOC tribunal. Id. at 47.
52. Id.
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53

Olympic sports, including professional cycling. The CAS’s “most
visible role” in the 1990s and 2000s has been arbitrating antidoping
54
disputes. WADA, IFs, and athletes may appeal antidoping decisions
55
by NGBs to the CAS, which then acts as the final arbiter with
56
respect to doping violations.
II. THE EVOLUTION OF ANTIDOPING EFFORTS IN SPORT
Antidoping efforts have traditionally been premised on the
direct detection of a prohibited substance in an athlete’s blood or
urine, typically through a positive doping test. Increasingly, however,
antidoping authorities have explored new approaches to pursuing
doping violations in the absence of positive doping tests.
A. Traditional Antidoping Controls: Direct Detection Through
Analytical Positive Findings
Traditional antidoping efforts have been aimed at directly
57
detecting prohibited substances. WADA maintains a list of such
58
59
60
banned substances, including both exogenous and endogenous

53. Weston, supra note 43, at 18.
54. Connolly, supra note 17, at 164.
55. See UNION CYCLISTE INTERNATIONALE, supra note 21, at 63–66 (outlining the
procedure for appealing to the CAS). The CAS reviews the facts and law in such cases de novo.
Weston, supra note 43, at 22.
56. Connolly, supra note 17, at 165; see also Types of Disputes Submitted to the CAS,
COURT OF ARBITRATION FOR SPORT, http://www.tas-cas.org/en/infogenerales.asp/4-3-239-10114-1-1/5-0-1011-3-0-0 (last visited Oct. 7, 2011) (“[Antidoping] disciplinary cases are generally
dealt with in the first instance by the competent sports authorities, and subsequently become the
subject of an appeal to the CAS, which then acts as a court of last instance.”).
57. See UNION CYCLISTE INTERNATIONALE, supra note 12, at 16 (“Before the introduction
of the biological passport, the anti-doping fight used only direct methods of detection. A blood
or urine sample was taken from a rider, then analysed to detect prohibited substances or
highlight whether a doping method had been used (such as a blood transfusion). If the threshold
of a prohibited substance was exceeded, or any illegal manipulations detected, sanctions were
imposed.”); WORLD ANTI-DOPING AGENCY, ATHLETE BIOLOGICAL PASSPORT OPERATING
GUIDELINES AND COMPILATION OF REQUIRED ELEMENTS 3 (2010), available at http://www.
wada-ama.org/Documents/Resources/Guidelines/WADA_ABP_OperatingGuidelines_EN_2.1
.pdf (“The typical Doping Control approach [is] based on the detection of Markers of a
substance or its Metabolites . . . .” (emphasis omitted)).
58. WORLD ANTI-DOPING AGENCY, THE 2011 PROHIBITED LIST, supra note 35.
59. An exogenous substance is “not ordinarily capable of being produced by the body
naturally,” and an analytical positive finding of an exogenous substance at any level may signal a
doping violation. Id. at 1.
60. An endogenous substance “is capable of being produced by the body naturally.” Id. A
finding that an endogenous substance exceeds a predetermined ratio may signal a doping
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substances. Article 2.1 of the Code provides that the “Presence of a
Prohibited Substance or its Metabolites or Markers in an Athlete’s
61
Sample” constitutes a doping violation. Under Article 2.1, an athlete
must test positive for a prohibited substance—a result known as an
analytical positive finding—before being found guilty of committing a
62
doping violation.
In the event of an analytical positive finding, the Code
guarantees an athlete’s right to a fair hearing. Specifically, the Code
provides as follows:
The [antidoping] hearing process shall respect the following
principles:
 a timely hearing;
 a fair and impartial hearing panel;
 the right to be represented by counsel at the Person’s own
expense; the right to be informed in a fair and timely manner of
the asserted anti-doping rule violation;
 the right to respond to the asserted anti-doping rule violation
and resulting Consequences;
 the right of each party to present evidence, including the right to
call and question witnesses (subject to the hearing panel’s
discretion to accept testimony by telephone or written
submission);
 the Person’s right to an interpreter at the hearing, with the
hearing panel to determine the identity, and responsibility for
the cost, of the interpreter; and
 a timely, written, reasoned decision, specifically including an
63
explanation of the reason(s) for any period of Ineligibility.

violation because it indicates that “the concentration of the substance in the specimen so
deviates from the range of values normally found in humans that it is unlikely to be consistent
with normal endogenous production.” Jessica K. Foschi, A Constant Battle: The Evolving
Challenges in the International Fight Against Doping in Sport, 16 DUKE J. COMP. & INT’L L. 457,
471–72 (2006). Doping violations based on endogenous-substance ratios are a “hotly contested
issue,” id. at 472, and raise a number of the same concerns as cycling’s biological passport.
61. WORLD ANTI-DOPING AGENCY, supra note 2, at 19 (emphasis added) (emphasis
omitted). This is the first doping violation enumerated in the Code. Id.
62. Id.
63. Id. at 48–49. Although these basic principles ensure athletes’ rights to a fair hearing,
athletes are not afforded the same due process protections as are embodied in the Fourteenth
Amendment. Meredith Lambert, The Competing Justices of Clean Sport: Strengthening the
Integrity of International Athletics While Affording a Fair Process for the Individual Athlete
Under the World Anti-Doping Program, 23 TEMP. INT’L & COMP. L.J. 409, 418–19 (2009).
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In an analytical positive case, the antidoping authority has the
64
burden of proving that the athlete has committed a doping violation.
The standard of proof in such a case is “whether the Anti-Doping
Organization has established a doping violation to the comfortable
satisfaction of the hearing panel bearing in mind the seriousness of
65
the allegation which is made.” According to the Code, this
comfortable-satisfaction standard is “greater than a mere balance of
66
probability but less than proof beyond a reasonable doubt.” In other
words, the “rigor [of this standard] lies somewhere between what is
normally applied in private law and what is applied under public
67
(penal or criminal) law.”
Analytical positive cases present relatively straightforward
68
evidentiary issues because the Code provides for strict liability in
69
such cases. Under the Code, each athlete has a “personal duty to
70
ensure that no Prohibited Substance enters his or her body.” A
doping violation thus occurs “whenever a Prohibited Substance is
found in an Athlete’s Sample,” regardless of whether the athlete
“intentionally or unintentionally Used a Prohibited Substance or was
71
negligent or otherwise at fault.” Therefore, a positive doping test
72
alone will typically suffice to prove an athlete guilty of doping.

64.
65.
66.
67.

WORLD ANTI-DOPING AGENCY, supra note 2, at 26.
Id. (emphasis added).
Id.
James A.R. Nafziger, Circumstantial Evidence of Doping: BALCO and Beyond, 16
MARQ. SPORTS L. REV. 45, 51 (2005).
68. Paul Greene, Case Note, United States Anti-Doping Agency v. Montgomery: Paving a
New Path to Conviction in Olympic Doping Cases, 59 ME. L. REV. 149, 157 (2007).
69. WADA relied on the CAS’s reasoning in a previous antidoping arbitration to justify
the use of the strict-liability standard in the Code. See USA Shooting & Q. v. Union
Internationale de Tir, No. CAS 94/129, at 6 (Ct. of Arb. for Sport 1995), http://jurisprudence.tascas.org/sites/CaseLaw/Shared%20Documents/129.pdf (“It is true that a strict liability test is
likely in some sense to be unfair in an individual case, such as that of Q., where the athlete may
have taken medication as the result of mislabelling or faulty advice for which he or she is not
responsible . . . . But it is also in some sense ‘unfair’ for an athlete to get food poisoning on the
eve of an important competition. Yet in neither case will the rules of the competition be altered
to undo the unfairness. Just as the competition will not be postponed to await the athlete’s
recovery, so the prohibition of banned substances will not be lifted in recognition of its
accidental absorption. The vicissitudes of competition, like those of life generally, may create
many types of unfairness, whether by accident or the negligence of unaccountable persons,
which the law cannot repair.”).
70. WORLD ANTI-DOPING AGENCY, supra note 2, at 19 (emphasis omitted).
71. Id.
72. A doping violation in an analytical positive case is proven by “direct evidence, where a
positive drug test will directly show that an athlete had a prohibited substance in [his] body.”

HAILEY IN FR

404

10/13/2011 9:50:35 AM

DUKE LAW JOURNAL

[Vol. 61:393
73

Although this strict-liability standard may appear harsh,
analytical positive cases also provide certain safeguards for accused
athletes. For instance, an analytical positive finding generally requires
that both an “A” and “B” sample of the athlete’s blood or urine show
74
the presence of a prohibited substance. This requirement protects
against false positives and provides greater certainty that a doping
75
violation has occurred. Moreover, athletes have the opportunity to
present affirmative evidence showing that the analytical positive
finding resulted from procedural laboratory error rather than
76
doping. The Code, however, presumes the validity of tests
77
conducted in WADA-accredited laboratories, and it is extremely
78
difficult for athletes to rebut this mandatory presumption.
79
The direct-detection approach has certain limitations. For
example, some prohibited substances—like synthetic erythropoietin
(EPO), a hormone that enhances endurance by increasing oxygen in
the blood, a process otherwise known as “blood doping”—can be

McLaren, supra note 14, at 9. The analytical positive finding “alone provide[s] sufficient
evidence of the athlete’s guilt.” Greene, supra note 68, at 157.
73. In fact, one commentator argues that strict liability places an “insurmountable burden
on the athlete.” Foschi, supra note 60, at 479.
74. WORLD ANTI-DOPING AGENCY, supra note 2, at 20.
75. Testing both A and B samples provides “certainty regarding the integrity of testing
methods and collection, since an adverse finding in the A sample should also appear in the B
sample.” Bradley J. Schmalzer, A Vicious Cycle: The Biological Passport Dilemma, 70 U. PITT.
L. REV. 677, 684 (2009). According to WADA, this procedure “helps confirm that an antidoping rule violation has occurred and protects the rights of the athletes.” Press Release, World
Anti-Doping Agency, WADA Clarifies B-Sample Procedure (Nov. 22, 2006), available at http://
www.wada-ama.org/en/News-Center/Articles/WADA-Clarifies-B-Sample-Procedure.
76. See WORLD ANTI-DOPING AGENCY, supra note 2, at 27 (“The Athlete or other Person
may . . . establish[] that a departure from the International Standard for Laboratories occurred
which could reasonably have caused the Adverse Analytical Finding.” (emphasis omitted)).
77. See id. (“WADA-accredited laboratories are presumed to have conducted Sample
analysis and custodial procedures in accordance with the International Standard for
Laboratories.” (emphasis omitted)).
78. Schmalzer, supra note 75, at 684.
79. See UNION CYCLISTE INTERNATIONALE, supra note 12, at 16 (“Indirect detection is a
lot more efficient than direct detection because the effects of using banned substances are
retained for a lot longer than the period during which it is possible to discover traces of the
substances in the body.”); WORLD ANTI-DOPING AGENCY, supra note 57, at 3 (“[Traditional
antidoping tests have] limitations when an Athlete may be using substances on an intermittent
and low-dose basis which may therefore go undetected under even the most robust Out-ofCompetition Doping Control program.” (emphasis omitted)); Wozny, supra note 13, at 79
(describing the limitations of traditional doping tests).
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80

directly detected in the body only for a few days. Other prohibited
81
substances may be impossible to detect using available doping tests.
Recognizing these limitations, antidoping authorities have begun to
pursue alternatives to direct detection.
B. New Antidoping Approaches: Nonanalytical Positive Cases
Antidoping authorities have increasingly explored newer
approaches to proving doping violations even in the absence of
positive doping tests. These efforts are known broadly as
82
nonanalytical positive cases. The right to a fair hearing, the burden
of proof, and the standard of proof are the same in nonanalytical
83
positive cases as in analytical positive cases. Because nonanalytical
positive cases do not involve a positive doping test, however, the
84
strict-liability standard does not apply. The relevant antidoping
authority has the burden of proving that a doping violation has
occurred through circumstantial—indirect—evidence or through
85
direct evidence other than an analytical positive finding. These cases
present challenges relating to the sufficiency of such evidence and the
fairness of finding an athlete guilty of doping in the absence of a
positive doping test.
The Code specifically provides that an athlete may be found
guilty of doping “where there is evidence that a doping violation
86
occurred but where there is no positive doping control test.” For

80. Susan Gilbert, The Biological Passport, HASTINGS CENTER REP., Mar.–Apr. 2010, at
18, 18.
81. Id.
82. McLaren, supra note 14, at 11.
83. See supra notes 63–67 and accompanying text.
84. Richard H. McLaren, An Overview of Non-Analytical Positive & Circumstantial
Evidence Cases in Sports, 16 MARQ. SPORTS L. REV. 193, 194 (2006). In other words, in
nonanalytical positive cases, there is “no positive drug test, no presumption of fault [on the part
of the athlete], and therefore no presumption [of guilt] for the athlete to rebut.” Lambert, supra
note 63, at 423.
85. McLaren, supra note 84, at 194. A nonanalytical positive case may involve “anything
other than a positive laboratory test.” Foschi, supra note 60, at 481.
86. World Anti-Doping Code, supra note 37. The potential scope of nonanalytical positive
cases is “really quite broad.” Cameron A. Myler, Resolution of Doping Disputes in Olympic
Sport: Challenges Presented by “Non-Analytical” Cases, 40 NEW ENG. L. REV. 747, 749 (2006)
(noting that nonanalytical positive cases could include “refusing to submit to drug testing,
admitting to the use of a substance, tampering with any part of the drug testing process, missing
three tests within an eighteen month period . . . , possessing substances, trafficking,
administering substances to other athletes . . . , encouraging, aiding, abetting, covering up, or
any other type of complicity involving an anti-doping rule violation”).
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instance, Article 2.2 of the Code provides that the “Use or Attempted
Use by an Athlete of a Prohibited Substance or a Prohibited Method”
87
constitutes a doping violation. Whereas an Article 2.1 violation
88
requires an analytical positive finding, an Article 2.2 violation may
89
instead “be established by any reliable means.” Such means may
include “admissions by the Athlete, witness statements, documentary
evidence, conclusions drawn from longitudinal profiling, or other
analytical information which does not otherwise satisfy all the
requirements to establish ‘Presence’ of a Prohibited Substance under
90
Article 2.1.”
A number of nonanalytical positive cases arose in the wake of
91
the Bay Area Laboratory Co-Operative (BALCO) doping scandal.
92
For instance, in United States Anti-Doping Agency v. Collins, the
93
U.S. Anti-Doping Agency (USADA) charged track-and-field
athlete Michelle Collins with using a variety of prohibited substances
provided by BALCO, including EPO, testosterone/epitestosterone
94
(T/E) cream, and tetrahydrogestrinone (THG). Collins had never
95
tested positive for a prohibited substance. Nevertheless, the North
96
American CAS relied exclusively on circumstantial evidence and
found “that Collins was guilty of doping through the use of prohibited
97
substances and techniques.”

87. WORLD ANTI-DOPING AGENCY, supra note 2, at 21 (emphasis omitted). This is the
second doping violation enumerated under the Code. Id.
88. See supra notes 61–62 and accompanying text.
89. WORLD ANTI-DOPING AGENCY, supra note 2, at 21 (emphasis added).
90. Id.
91. McLaren, supra note 14, at 10.
92. U.S. Anti-Doping Agency v. Collins, AAA No. 30 190 00658 04 (N. Am. Ct. of Arb. for
Sport 2004), http://www.usada.org/files/active/arbitration_rulings/AAA%20CAS%20Decision
%20-%20Collins.pdf.
93. USADA is the national antidoping organization that governs Olympic sports in the
United States. About USADA, U.S. ANTI-DOPING AGENCY, http://www.usada.org/about (last
visited Oct. 7, 2011).
94. Collins, AAA No. 30 190 00658 04, at 2–5.
95. Id. at 2.
96. The North American CAS operates as the American Arbitration Association (AAACAS). Straubel, supra note 18, at 1205.
97. Collins, AAA No. 30 190 00658 04, at 2. The Collins panel initially explained that
“USADA [was seeking] for the first time to sanction an athlete who ha[d] not tested positive in
any of her in-competition or out-of-competition drug tests” and thus that the case presented
“issues that ha[d] not previously had to be decided by Arbitral Tribunals.” Id. at 1. The panel,
however, found that “the straightforward application of legal principles to essentially
undisputed facts [led] to a clear resolution of this matter.” Id.

HAILEY IN FR

2011]

10/13/2011 9:50:35 AM

CYCLING’S BIOLOGICAL PASSPORT

407

The Collins panel relied primarily upon two sets of indirect
evidence of doping: (1) emails from Collins in which she admitted to
using prohibited substances and techniques; and (2) blood- and urinetest results indicating fluctuations in Collins’s hematocrit and T/E
98
ratios, which “together provide[d] solid evidence of a pattern of
99
doping.” The panel held that these two categories of circumstantial
evidence “independently and collectively” proved Collins’s use of
100
prohibited substances.
In a subsequent nonanalytical positive case, United States Anti101
Doping Agency v. M., USADA charged track-and-field athlete Tim
Montgomery with using a variety of prohibited substances provided
102
by BALCO. Similarly to Collins, Montgomery had never tested
positive for any prohibited substance. Instead, USADA relied
exclusively on other direct and circumstantial evidence to argue that
103
Montgomery had committed a doping violation. The M. panel
ultimately found Montgomery guilty of doping based on witness Kelli
White’s direct testimony that Montgomery had admitted his use of
104
prohibited substances to her. Nevertheless, the panel declined to
“determine whether the mass of other evidence”—including
fluctuations in Montgomery’s biological variables—was also
105
conclusive evidence of doping.

98. Id. at 2, 18–24.
99. Id. at 2. Because this case arose before the adoption of the Code, the Collins panel
applied the beyond-a-reasonable-doubt standard, id., rather than the comfortable-satisfaction
standard mandated under the Code, WORLD ANTI-DOPING AGENCY, supra note 2, at 26.
100. Collins, AAA No. 30 190 00658 04, at 16. With respect to the blood and urine tests
specifically, the Collins panel found that “[d]oping is the only potential explanation for the
extreme variations in both hematocrit levels and T/E ratios.” Id. at 24. According to the panel,
the fluctuations in Collins’s hematocrit levels proved that Collins had used EPO, whereas the
variations in her T/E levels could “only be explained by the illegal use of
[testosterone/epitestosterone] cream.” Id. at 22. The panel also noted that “Collins did not
present any expert’s testimony or any other evidence to provide an alternative explanation of
these test results.” Id. at 25.
101. U.S. Anti-Doping Agency v. M., No. CAS 2004/O/645 (Ct. of Arb. for Sport 2005),
http://jurisprudence.tas-cas.org/sites/CaseLaw/Shared%20Documents/645.pdf.
102. Id. at 1.
103. Id. For example, USADA presented fluctuations in biological variables in
Montgomery’s blood and urine as circumstantial evidence of an antidoping violation. Id.
104. The M. panel was “unanimously of the view that Mr. Montgomery in fact admitted his
use of prohibited substances to Ms. White.” Id. at 17. The panel characterized this admission as
“uncontroverted evidence of . . . a direct and compelling nature.” Id. at 20.
105. Id. at 2.

HAILEY IN FR

408

10/13/2011 9:50:35 AM

DUKE LAW JOURNAL

[Vol. 61:393

These and other nonanalytical positive cases have raised new
106
questions regarding the reliability of such evidence and the fairness
of finding an athlete guilty of doping in the absence of a positive
107
doping test. Whereas analytical positive cases involve relatively
108
straightforward evidentiary issues,
nonanalytical positive cases
present more difficult challenges. Because strict liability does not
apply, nonanalytical positive cases turn on the “value and weight of
the circumstantial evidence and the standard of proof that will be
109
applied to evaluate this evidence.” Unfortunately, there has been
“little guidance regarding . . . how much [evidence] is enough to
convict an athlete of a doping offense” in the absence of a positive
110
doping test. Although nonanalytical positive cases may provide a
111
valuable “new tool in the fight against doping,” it is also important
to balance the interest in conducting this fight with the fundamental
112
rights of accused athletes.
III. CYCLING’S BIOLOGICAL PASSPORT: A NEW COURSE IN THE
RACE AGAINST DOPING IN SPORT
Cycling’s biological passport marks a departure from traditional
antidoping efforts and signals an aggressive new approach to pursuing
113
nonanalytical positive cases.
The biological passport is an
106. Myler, supra note 86, at 751–52; see also Nafziger, supra note 67, at 47 (encouraging
“critical thinking about the alternatives to a reliance on hard, laboratory evidence” in
nonanalytical positive cases).
107. Nafziger, supra note 67, at 47 (“Arguably, the circumstantial nature of the evidence,
because of its indirectness, may be unreliable and unfair.”).
108. See supra notes 68–72 and accompanying text.
109. McLaren, supra note 84, at 194–95.
110. Foschi, supra note 60, at 481. Unfortunately, the Collins and M. decisions provided
“virtually no guidance on what must be proven in an entirely circumstantial evidence case
involving a non-analytical positive.” McLaren, supra note 84, at 212.
111. McLaren, supra note 14, at 11.
112. See Schmalzer, supra note 75, at 700 (“[A]nti-doping organizations must bear in mind
that for every rule and new testing method imposed on athletes, the rights of those same
athletes are curtailed.”).
113. This characterization is somewhat of an oversimplification. In fact, antidoping
organizations have long employed methods of indirect detection in addition to methods of
direct detection. For instance, WADA explicitly authorizes the monitoring of T/E ratios to
indirectly detect the use of prohibited substances. WORLD ANTI-DOPING AGENCY, GUIDELINE:
REPORTING AND MANAGEMENT OF ELEVATED T/E RATIOS 3 (2006), available at http://www.
wada-ama.org/Documents/Resources/Guidelines/WADA_Guidelines_ReportManagement
ElevatedTERatios_EN.pdf. In many ways, cycling’s biological passport is simply a variation on
earlier, indirect antidoping tests, such as the T/E ratio. Moreover, many of the criticisms levied
against the T/E ratio apply with similar force to cycling’s biological passport. See, e.g., James E.
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individual, electronic profile that collates various biological
114
Using these data,
parameters in a cyclist’s blood and urine.
antidoping authorities monitor an individual cyclist’s natural
biological variables for fluctuations that are thought to indirectly
115
reveal doping. Based on this analysis, the UCI may decide to
116
initiate disciplinary proceedings against a cyclist for doping.
Cycling’s biological passport is therefore premised on a theory of
117
indirect detection. The biological passport “doesn’t follow products,
but the athlete,” making it unnecessary to develop a new test for
118
every prohibited substance or method of doping. Instead of relying
on a positive doping test or other direct or circumstantial evidence of
doping, the UCI may initiate antidoping proceedings against a cyclist
solely on the basis of inferences drawn from fluctuations in that
cyclist’s biological variables. Although Pat McQuaid, UCI president,
heralded this approach as “a new and historic step in the fight against
119
doping,” this method raises serious concerns.
A. The Genesis of Cycling’s Biological Passport
120

WADA initially conceived of the biological passport in 2002.
In January 2008, the UCI became the first IF to implement a

Coleman, Jr. & Joshua M. Levine, The Burden of Proof in Endogenous Substance Cases: A
Masking Agent for Junk Science, in DOPING AND ANTI-DOPING POLICY IN SPORT: ETHICAL,
LEGAL AND SOCIAL PERSPECTIVES 27, 32 (Mike McNamee & Verner Møller eds., 2011)
(noting “serious scientific uncertainty about the validity of the [T/E] ratio as a proxy for the
exogenous use of testosterone”). Nevertheless, antidoping organizations, commentators, and
the media continue to speak in terms of “traditional direct detection” versus “indirect detection
under the biological passport.” Wozny, supra note 13, at 79.
114. Questions & Answers on the Athlete Biological Passport, WORLD ANTIDOPING AGENCY, http://www.wada-ama.org/en/Science-Medicine/Athlete-Biological-Passport/
Questions-Answers (last updated Dec. 2009).
115. See supra note 15.
116. UNION CYCLISTE INTERNATIONALE, supra note 12, at 20.
117. Id. at 16 (“With the biological passport, the direct detection of substances is not the
primary focus, but rather the effect of these substances on the body. . . . This is called indirect
detection.”).
118. Jamey Keaton, WADA Joins Cycling Body in Support of Latest Anti-Doping Plan,
ASSOCIATED PRESS, Oct. 23, 2007, available at Factiva, Doc. No. APRS000020071023e3an
0031u.
119. Julien Pretot, McQuaid Hails Historic Step in Fight Against Doping, REUTERS, Oct. 23,
2007, available at Factiva, Doc. No. LBA0000020071023e3an000o0 (quoting McQuaid) (internal
quotation mark omitted).
120. Questions & Answers, supra note 114. As has been the case with many antidoping
initiatives, the program did not gain momentum until a major doping scandal several years later.
At the 2006 Olympics in Turin, a dozen cross-country skiers were suspended from competition
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121

biological-passport program. The UCI formally incorporated the
biological passport into its antidoping rules in June 2008, enabling the
antidoping authority to begin sanctioning cyclists for doping on the
122
basis of indirect biological-passport evidence.
Under cycling’s biological passport, professional cyclists may be
required to submit to mandatory blood and urine tests at any time,
123
both in and out of competition. In the first five months of 2008, the
UCI took 3,185 blood and urine samples from more than 850
124
professional cyclists. The UCI then analyzed these initial samples to
create the longitudinal blood and steroid profiles in each cyclist’s
125
biological passport.
These profiles established the cyclist’s
126
such as
individual parameters for various biological variables,
hemoglobin, reticulocytes, and hematocrit, all of which are found in
127
the blood.
Using these profiles, the UCI can compare an individual cyclist’s
subsequent blood and urine samples against the historical parameters
128
Based on this
contained in that cyclist’s biological passport.
comparison, the UCI may conclude that fluctuations in a cyclist’s
blood profile are abnormal and likely indicate prohibited blood

because of excessive levels of hemoglobin in their blood. Lynn Zinser & Juliet Macur, Pomp
and Unsettling Circumstances Open Games, N.Y. TIMES, Feb. 11, 2006, at D1. Although these
elevated levels may have indicated blood doping, the athletes maintained that their hemoglobin
levels were natural. Id. Following this episode, WADA financed a research program to explore
the possibility of developing a biological passport. Macur, supra note 8.
121. Information on the Biological Passport, UNION CYCLISTE INTERNATIONALE (Dec. 21,
2007), http://www.uci.ch/Modules/ENews/ENewsDetails.asp?MenuId=&id=NTQzOA. The UCI
first announced these plans in October 2007. Macur, supra note 8.
122. Press Release, Union Cycliste Internationale, UCI Management Committee Meeting in
Denmark (June 13, 2008), available at http://www.uci.ch/Modules/ENews/ENewsDetails.asp?
id=NTg0Nw. The UCI also adopted a no-start rule, meaning that a cyclist could be prevented
from starting a race for fifteen days based on his biological passport. UCI Votes To Incorporate
Biological Passport in Fight Against Doping, ASSOCIATED PRESS, June 13, 2008, available at
Factiva, Doc. No. APRS000020080613e46d008gc.
123. Cyclists are required to provide the UCI with a detailed schedule of their whereabouts
through the Anti-Doping Administration & Management System (ADAMS) program. UNION
CYCLISTE INTERNATIONALE, supra note 12, at 19. This requirement enables the UCI to test
cyclists at any time. Id.
124. Cycling’s Governing Body Prepares New ‘No-Start’ Anti-Doping Rule, ASSOCIATED
PRESS, June 6, 2008, available at Factiva, Doc. No. APRS000020080606e46600c4o.
125. UNION CYCLISTE INTERNATIONALE, supra note 12, at 15.
126. Id. at 16.
127. Biological Passport—Questions/Answers, supra note 13.
128. UNION CYCLISTE INTERNATIONALE, supra note 12, at 18–19.
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129

Similarly, the UCI may
manipulation, such as blood doping.
determine that irregularities in a cyclist’s steroid profile reveal that
the cyclist has taken exogenous steroids, such as testosterone, that
130
may not have been detected by traditional tests.
Biological passports are monitored using a two-step process.
First, each blood or urine sample is analyzed and then applied against
a statistical model that uses Bayesian inference techniques to
compare the individual sample against the cyclist’s historical
131
If there are fluctuations in a cyclist’s biological
parameters.
parameters that exceed the thresholds set by the statistical model, the
model makes the initial determination that the cyclist is likely to have
132
committed a doping violation. This determination is based not on a
“true probability of doping,” but instead on “how the profile differs
133
from what is expected in clean athletes.”
Second, any biological-passport data that might indicate doping
are submitted to a UCI panel of three antidoping experts for further
134
review. These experts interpret the data to determine whether the
fluctuations in a cyclist’s biological variables indirectly show that the
135
cyclist has committed a doping violation. The panel then issues a
recommendation as to whether the UCI should take formal action,
such as initiating disciplinary proceedings against the cyclist for
136
doping.

129. Id. at 16.
130. Id. The UCI has not yet fully implemented the steroid profile. Thus far, it has relied
exclusively on blood-profile fluctuations in prosecuting all biological-passport cases. Biological
Passport—Questions/Answers, supra note 13.
131. Union Cycliste Internationale, The Biological Passport: A New Element in “100%
Against Doping,” ASS’N OF NAT’L ANTI-DOPING ORGS., 20–21 (Mar. 31, 2008), http://www.
anado.org/documents/UCI.pdf. The Bayesian model makes a “statistical inference in which
evidence or observations are used to update or to newly infer the probability that a hypothesis
[of doping] may be true.” Id. at 21 (emphasis omitted).
132. The Athlete Biological Passport (ABP), LABORATOIRE SUISSE D’ANALYSE DU
DOPAGE, http://www.doping.chuv.ch/en/lad_home/lad-prestations-laboratoire/lad-prestationslaboratoire-passeport.htm (last updated Nov. 16, 2009). Typically, this model uses a specificity
of 99 percent. Id.
133. Id. (internal quotation marks omitted).
134. Ryan, supra note 1.
135. The Athlete Biological Passport, supra note 132.
136. UNION CYCLISTE INTERNATIONALE, supra note 12, at 20.
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The UCI has discretion as to whether to initiate such
137
proceedings. If the UCI opts to pursue enforcement on the basis of
indirect biological-passport evidence, it will provisionally suspend the
accused cyclist from competition and formally request that the
138
relevant NGB sanction the cyclist for doping. The accused cyclist
139
has the right to a hearing before his NGB. At the conclusion of that
proceeding, the NGB will determine whether the cyclist is guilty of
140
doping and, if necessary, will impose sanctions. WADA, the UCI,
and the accused cyclist then have the right to appeal the NGB’s
141
142
decision to the CAS, which will render a final decision.
B. The First Cases Arising Under Cycling’s Biological Passport
In 2009 and 2010, the UCI opened the first antidoping cases
based on cycling’s biological passport. The UCI initiated two waves of
disciplinary proceedings against a total of eight cyclists suspected of
doping solely on the basis of fluctuations in their biological passports.
In these cases, the cyclists’ NGBs initially disagreed with one another
over the reliability of such evidence in proving doping violations. In
the four cases that were appealed, however, CAS panels consistently
upheld the doping sanctions. The CAS therefore signaled a broad
willingness to accept indirect biological-passport evidence as proof of
doping.
1. NGBs Split on the Reliability of Cycling’s Biological Passport.
NGBs initially split in antidoping cases arising under cycling’s
biological passport. In the first wave of proceedings involving indirect
biological-passport evidence, NGBs appeared to signal their broad
support for the program by unanimously upholding doping sanctions.
In the second wave of proceedings arising under the program,
however, NGBs voiced concerns over the reliability of indirect
biological-passport evidence and subsequently declined to uphold
doping sanctions based on such evidence alone.

137. See UNION CYCLISTE INTERNATIONALE, supra note 21, at 41 (“[T]he UCI shall
conclude whether an anti-doping violation has apparently been committed.”); id. at 42 (“[T]he
UCI may reopen the case on its own initiation.”).
138. See infra notes 150–156 and accompanying text.
139. See supra note 63 and accompanying text.
140. See supra notes 23, 51 and accompanying text.
141. See supra note 55 and accompanying text.
142. See supra note 56 and accompanying text.
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In the first wave of antidoping proceedings, NGBs unanimously
upheld the UCI’s sanctions. In June 2009, the UCI provisionally
suspended five cyclists—Spaniards Igor Astarloa Ascasibar, Ruben
Lobato Elvira, and Ricardo Serrano Gonzalez and Italians Pietro
Caucchioli and Francesco De Bonis—on the basis of “information
143
provided by the blood profile in [the cyclists’] biological passports.”
Subsequently, the UCI formally requested that the Spanish and
Italian NGBs open disciplinary proceedings against the five accused
144
cyclists. The cyclists vigorously maintained their innocence, arguing
145
that they had not tested positive for any prohibited substances.
146
Although the cyclists were not major names in the sport, the UCI
called the announcement a “very important step in the battle against
147
and a “significant breakthrough” for the biological
doping”
148
passport. The cyclists faced minimum two-year bans from their
NGBs, but the UCI announced that it would seek four-year bans in
149
an effort to demonstrate its confidence in the strength of the cases.
The Italian and Spanish NGBs ultimately found all five cyclists
guilty of doping. In May 2010, De Bonis became the first cyclist to be
sanctioned for a doping violation based solely on indirect biologicalpassport evidence when the National Anti-Doping Tribunal of the
Italian Anti-Doping Department (CONI) levied a two-year
150
suspension and a €13,000 fine against him. The UCI emphasized the

143. Press Release, Union Cycliste Internationale, Commencement of First Disciplinary
Proceedings on the Basis of the Biological Passport (June 17, 2009), available at http://www.uci.
ch/Modules/ENews/ENewsDetails.asp?id=NjM5OA.
144. Juliet Pretot, UCI Disciplines Five over Biological Passport, REUTERS, June 17, 2009,
available at Factiva, Doc. No. LBA0000020090617e56h0010v.
145. For example, De Bonis insisted, “All the tests I have done throughout the year,
including the Giro d’Italia, have been all negative. . . . [A]ll of my samples taken at
home . . . were all negative.” Gregor Brown, UCI Names First Five Biological Passport
Violators, CYCLING NEWS (June 17, 2009, 11:00 AM), http://www.cyclingnews.com/news/ucinames-first-five-biological-passport-violators (quoting De Bonis) (internal quotation marks
omitted).
146. Pretot, supra note 144.
147. Press Release, Union Cycliste Internationale, supra note 143.
148. Richard Moore, UCI ‘Blood Passports’ Investigation Names Doping Suspects,
GUARDIAN (June 17, 2009, 15:59 EDT), http://www.guardian.co.uk/sport/2009/jun/17/cyclingdrugs-riders-named-uci.
149. UCI Calls for Doping Charges Against 5 Riders, ASSOCIATED PRESS, June 17, 2009,
available at Factiva, Doc. No. APRS000020090617e56h001ja.
150. Press Release, Union Cycliste Internationale, Biological Passport: First Sanction (May
27, 2010), available at http://www.uci.ch/Modules/ENews/ENewsDetails.asp?id=Njg5Mw.
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“historic importance of this first judgment under the scope of the
151
biological passport” program.
Subsequently, in June 2010, the CONI tribunal imposed a two152
year ban on Caucchioli. Then, the Disciplinary Commission of the
Spanish RFEC announced a two-year suspension and a €23,100 fine
153
for Serrano in June 2010 and a two-year ban for Lobato in July
154
2010. Finally, the RFEC tribunal levied a two-year suspension and a
155
€35,000 fine against Astarloa in December 2010, despite the fact
156
that the cyclist had retired from the sport the previous year. These
initial decisions appeared to signal the Italian and Spanish NGBs’
willingness to accept indirect biological-passport evidence as proof of
doping.
In the second wave of antidoping proceedings, however, multiple
NGBs declined to impose doping sanctions and instead questioned
the scientific and legal validity of indirect biological-passport
evidence. In May 2010, the UCI provisionally suspended three
cyclists—Italian Franco Pellizotti, Spaniard Jesus Rosendo Prado,
and Slovenian Tadej Valjavec—and requested that their respective
157
NGBs initiate disciplinary proceedings against them. The cyclists

151. Id.
152. Press Release, Union Cycliste Internationale, Biological Passport: Pietro Caucchioli
Sanctioned (June 3, 2010), available at http://www.uci.ch/Modules/ENews/ENewsDetails.asp?
id=NjkwOA.
153. In addition to fluctuations in his biological-passport variables, Serrano was found guilty
of doping based on a later analytical positive finding of prohibited recombinant EPO (CERA)
in his blood. Press Release, Union Cycliste Internationale, Biological Passport: Ricardo Serrano
Gonzalez Sanctioned (June 17, 2010), available at http://www.uci.ch/Modules/ENews/ENews
Details.asp?id=NjkyMw.
154. Press Release, Union Cycliste Internationale, Biological Passport: Ruben Lobato
Sanctioned (July 27, 2010), available at http://www.uci.ch/Modules/ENews/ENewsDetails.asp?
id=Njk3MQ.
155. Press Release, Union Cycliste Internationale, Biological Passport: Igor Astarloa
Askasibar Sanctioned (Dec. 1, 2010), available at http://www.uci.ch/Modules/ENews/ENews
Details.asp?id=NzE1NA.
156. Astarloa was exasperated, saying, “It seems absurd to me. . . . [E]ven when you’re
retired, they don’t leave you in peace. I could say I don’t care, because I’m no longer a
cyclist . . . , but . . . it’s unjust. They controlled me a thousand time [sic], any hour, any place, and
I was never positive.” Astarloa Calls Sanctions “Absurd and Ridiculous,” CYCLING NEWS (Dec.
2, 2010, 2:13 PM), http://www.cyclingnews.com/news/astarloa-calls-sanctions-absurd-andridiculous (quoting Astarloa) (internal quotation marks omitted).
157. Press Release, Union Cycliste Internationale, Commencement of Disciplinary
Proceedings on the Basis of the Biological Passport (May 3, 2010), available at http://www.uci.
ch/Modules/ENews/ENewsDetails.asp?id=NjM5OA.

HAILEY IN FR

2011]

10/13/2011 9:50:35 AM

CYCLING’S BIOLOGICAL PASSPORT

415

158

Pellizotti was the first
vehemently denied any wrongdoing.
prominent cyclist accused of a doping violation based on indirect
biological-passport evidence, and his suspension was viewed as
signaling that the UCI was finally getting “serious about rooting out
159
dopers.”
In July 2010, a disciplinary panel of Slovenia’s National AntiDoping Commission (NADC) became the first NGB to question the
reliability of indirect biological-passport evidence when the panel
160
In its
declined to impose doping sanctions against Valjavec.
decision, the NADC panel broadly rejected evidence from Valjavec’s
biological passport, finding that his profile provided insufficient proof
161
of prohibited blood doping. Instead, the panel accepted Valjavec’s
argument that his biological-passport anomalies could have been
caused by a variety of physiological factors other than blood doping,
such as bleeding due to a stomach ulcer, training at high altitudes and
in a hypobaric chamber, and corticoid treatment following a wasp
162
sting. Specifically, the NADC panel found that “the statistical
methods adopted by the biological passport cannot demonstrate the
use of doping techniques but only evidence eventual unusual value[s]
163
that could be explained by physiological origins.” Moreover, the
NADC panel held that the UCI had “failed to prove that the model
of the biological passport had been used correctly and that it factored
in variables, such as the type of instrument and altitude at which

158. Valjavec was stunned by the announcement, saying, “I can’t believe how it is possible
that the system does not work and that this can happen.” Susan Westemeyer, Valjavec Claims
Innocence in Biological Passport Case, CYCLING NEWS (May 4, 2010, 2:30 PM), http://www.
cyclingnews.com/news/valjavec-claims-innocence-in-biological-passport-case (quoting Valjavec)
(internal quotation marks omitted).
159. Juliet Macur, Blood Profile Is Foundation for Barring of Cyclist, N.Y. TIMES, May 8,
2010, at D3. Pellizotti’s Team Liquigas fired back, arguing that “[t]he evidence which has been
presented [through the biological passport] does not seem to scientifically prove with certainty
any improper conduct by the athlete.” Id. (quoting a statement by Team Liquigas) (internal
quotation mark omitted).
160. Cyclist Valjavec Cleared of Doping Charges, SLOVN. PRESS AGENCY (July 29, 2010,
12:42 PM), http://www.sta.si/en/vest.php?s=a&t=0&id=1539082.
161. Id.
162. Stephen Farrand, UCI Takes the Tadej Valjavec Case to the Court of Arbitration,
CYCLING NEWS (Sept. 18, 2010, 11:11 AM), http://www.cyclingnews.com/news/uci-takes-thetadej-valjavec-case-to-the-court-of-arbitration.
163. Id.
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164

Valjavec had trained.” As a result, the NADC panel declined to
165
impose doping sanctions against Valjavec.
In October 2010, a CONI tribunal likewise rejected indirect
biological-passport evidence and declined to impose doping sanctions
against Pellizotti. Pellizotti maintained his innocence before the
CONI panel, and several hematological experts testified on his
166
behalf. Dr. Roberto Corsetti, Pellizotti’s Team Liquigas doctor,
testified that Pellizotti’s biological-passport fluctuations could be
explained by natural causes, including altitude training, that the
“math formula [of the biological passport] does not take into
167
Dr. Giancarlo Isacchi, an independent expert
consideration.”
witness for the CONI tribunal, similarly argued that anomalies in
Pellizotti’s biological passport did not yield “a significant probability”
168
that Pellizotti had engaged in doping. In perhaps a surprising
change of course from its pair of decisions only a few months
169
earlier, the CONI panel ultimately held that the evidence from
Pellizotti’s biological passport did not establish “a sufficient
170
probability of guilt” of doping. As a result, the panel dismissed the
171
UCI’s case for lack of evidence and fined the UCI €5,000 in court
172
costs. Following the decision, Pellizotti announced that he planned
173
to seek €200,000 in damages from the UCI.

164. Cyclist Valjavec Cleared of Doping Charges, supra note 160.
165. Id.
166. Gregor Brown, Pellizotti’s Biological Passport Lacked Certainty, Says Expert, CYCLING
WEEKLY (Oct. 22, 2010), http://www.cyclingweekly.co.uk/news/latest/504199/pellizotti-sbiological-passport-lacked-certainty-says-expert.html.
167. Id. (alteration in original).
168. Id.
169. See supra notes 150–152 and accompanying text.
170. Andrew Dampf, Italian Cyclist Franco Pellizotti Cleared of Doping in Biological
Passport Case, ASSOCIATED PRESS, Oct. 21, 2010, available at Factiva, Doc. No. APRS
000020101021e6al001am; see also Italian Cyclist Cleared in Suspected Drug Case, AGENCE
FRANCE-PRESSE, Oct. 21, 2010, available at Factiva, Doc. No. AFPR000020101021e6al006n3
(reporting that the court had held that a “sufficiently high level of probability of guilt wasn’t
established” and had “absolve[d] the rider of the charge”).
171. Italian Cyclist Cleared in Suspected Drug Case, supra note 170.
172. Banned Cyclist Pietro Caucchioli To Challenge Validity of UCI’s Biological Passport,
VELONEWS (Oct. 26, 2010, 10:40 AM UTC), http://velonews.competitor.com/2010/10/news/
banned-cyclist-pietrio-caucchioli-to-challenge-validity-of-ucis-biological-passport_147751.
173. Cyclist Pellizotti Suing UCI for Damages, ASSOCIATED PRESS, Jan. 6, 2011, available at
Factiva, Doc. No. APRS000020110106e716001hy.
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Finally, Rosendo never faced disciplinary proceedings for his
174
Rosendo’s Andalucia-Cajasur team
alleged doping violation.
announced that the irregularities in the cyclist’s biological passport
175
had likely been caused by abundant bleeding due to a hemorrhoid.
As a result, the RFEC declined the UCI’s request to open disciplinary
176
proceedings against Rosendo. Collectively, these decisions cast
177
doubt on the future of cycling’s biological passport.
2. The CAS Accepts Indirect Biological-Passport Evidence.
Whereas NGBs initially disagreed over the reliability of cycling’s
biological passport, the CAS subsequently signaled a broad
willingness to accept indirect biological-passport evidence by
upholding doping sanctions against cyclists. The CAS heard appeals
178
in four of the initial eight biological-passport cases. Caucchioli
became the first cyclist to challenge the validity of the biological179
passport program before a CAS panel in December 2010. CAS
180
181
De Bonis,
and
panels also heard appeals in the Valjavec,
182
Pellizotti cases in early 2011. In each case, the CAS panel ultimately
upheld the imposition of doping sanctions based on indirect
biological-passport evidence.
In March 2011, the CAS found both Caucchioli and Pellizotti
guilty of doping based on indirect biological-passport evidence

174. Hedwig Kröner, Valjavec Cleared by Slovenian Anti-Doping Agency, CYCLING NEWS
(July 30, 2010, 4:11 PM), http://www.cyclingnews.com/news/valjavec-cleared-by-slovenian-antidoping-agency.
175. Id.
176. Id.
177. Juliet Macur, Ban Based on Blood Profile Is Upheld, N.Y. TIMES, Mar. 9, 2011, at B16
(noting that “cycling’s biological passport program seemed to be on shaky ground”).
178. CAS Sets Court Dates for Riders De Bonis, Pellizotti To Challenge Cycling’s AntiDoping Scheme, ASSOCIATED PRESS, Feb. 18, 2011, available at Factiva, Doc. No. APRS
000020110218e72i001bp.
179. Caucchioli Tests Cycling Anti-Doping Scheme at CAS, ASSOCIATED PRESS, Dec. 21,
2010, available at Factiva, Doc. No. APRS000020101221e6cl0029u.
180. The CAS heard the UCI’s appeal of the NADC tribunal’s decision in the Valjavec case
in January 2011. Id.
181. The CAS heard De Bonis’s appeal of the CONI panel’s decision in his case in February
2011. Italian Cyclist De Bonis in Sports Court To Fight Biological Passport Doping Case,
ASSOCIATED PRESS, Feb. 25, 2011, available at Factiva, Doc. No. APRS000020110225e72p
002nc.
182. The CAS heard the UCI’s and Pellizotti’s appeals of the CONI tribunal’s decision in
the Pellizotti case in March 2011. Italian Cyclist Franco Pellizotti Faces UCI in Court Test of
Passport Anti-Doping Method, ASSOCIATED PRESS, Mar. 2, 2011, available at Factiva, Doc. No.
APRS000020110302e732002cu.
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183

alone. In the Caucchioli case, the CAS panel held that “the strict
application of [the biological passport] could be considered as a
184
reliable means of detecting indirect doping methods.” Moreover,
the CAS panel found that “the ‘irregularities’ put forward by
[Caucchioli] could not have affected the results” reflected in the
185
cyclist’s biological passport. Therefore, the CAS panel found that
the UCI had “successfully established the use of prohibited doping
methods,” and it affirmed the CONI tribunal’s decision to impose a
186
two-year ban on Caucchioli.
In the Pellizotti case, the CAS panel overturned the CONI
panel’s decision clearing Pellizotti and instead found the cyclist guilty
187
of doping. The CAS panel found that fluctuations in Pellizotti’s
biological passport were sufficient to prove the cyclist had engaged in
188
prohibited blood doping. As a result, the CAS panel suspended
Pellizotti for two years, disqualified his race results dating back to
189
May 2009, and fined him €115,000. The UCI and WADA hailed
190
these decisions as broadly vindicating cycling’s biological passport.

183. Press Release, Court of Arbitration for Sport, The Court of Arbitration for Sport
(CAS) Imposes a Two Year Ban on the Italian Cyclists Pietro Caucchioli and Franco Pellizotti
1–2 (Mar. 8, 2011), available at http://www.tas-cas.org/d2wfiles/document/4615/5048/0/press%20
release%20ANG_2010%2003%2008.pdf.
184. Id.
185. Id.
186. Id. at 2.
187. Id.
188. Id.
189. Graham Dunbar, UCI Wins Landmark Anti-Doping Verdicts as CAS Bans Italian
Riders Pellizotti, Caucchioli, ASSOCIATED PRESS, Mar. 8, 2011, available at Factiva, Doc. No.
APRS000020110308e738002go; see also Press Release, Court of Arbitration for Sport, supra
note 183, at 1 (“[T]he CAS Panel has reviewed in detail the biological passport program applied
by the UCI and has found that the strict application of such program could be considered as a
reliable means of detecting indirect doping methods.”).
190. See Press Release, Union Cycliste Internationale, CAS Acknowledges Validity of
Biological Passport (Mar. 9, 2011), available at http://www.uci.ch/Modules/ENews/ENews
Details.asp?id=NzI0NA (“The [CAS] decisions . . . confirm the validity of the biological
passport as an essential instrument in the fight against doping, which will most certainly become
part of the arsenal of other international sporting federations that wish to draw on the UCI’s
experience.”); Press Release, World Anti-Doping Agency, WADA Satisfied with CAS
Recognition of Athlete Biological Passport as Valid Instrument (Mar. 9, 2011), available at
http://www.wada-ama.org/en/News-Center/Articles/WADA-satisfied-that-Athlete-BiologicalPassport-recognized-by-CAS-as-valid-instrument-in-the-fight (“The [biological passport] has
proven it can withstand legal and scientific challenges.”).
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In April 2011, the CAS similarly found Valjavec guilty of doping
191
based on indirect biological-passport evidence. The CAS reversed
the NADC panel’s initial decision clearing Valjavec and instead
levied a two-year suspension against the cyclist, disqualified his race
results between April 2009 and September 2009, and fined him
192
The CAS panel concluded that “anti-doping tests
€52,500.
performed in April and August 2009 revealed abnormalities in the
context of the athlete’s biological passport to a degree which was
193
entirely consistent with blood manipulation.” Moreover, the CAS
panel explicitly “confirmed the reliability of the indirect method of
194
detection based on the blood profile of athletes . . . .” Subsequently,
the UCI announced that it was “extremely satisfied because this CAS
verdict [had] once again given support to the reliability of the
195
biological passport.”
Finally, in June 2011, the CAS dismissed De Bonis’s appeal and
196
upheld the CONI tribunal’s doping sanctions against the cyclist. In
doing so, the CAS again confirmed its position that the biological
197
passport is “a reliable means of proving an anti-doping violation.”
Although CAS panels are not necessarily bound by the
precedent of prior arbitration proceedings or obliged to obey the
198
rules of stare decisis, the CAS has signaled a broad willingness to
accept indirect biological-passport evidence in finding cyclists guilty
of doping, and subsequent CAS panels will likely continue to uphold
199
such sanctions.

191. Charles Pelkey, Court of Arbitration for Sport Rules in Favor of UCI, Suspends Tadej
Valjavec, VELONEWS (Apr. 22, 2011, 9:28 AM UTC), http://velonews.competitor.com/2011/04/
news/court-of-arbitration-for-sport-rules-in-favor-of-uci-suspends-tadej-valjavec_169785.
192. Id.
193. Graham Dunbar, Slovenia’s Valjavec Gets 2-Year Ban for Doping, Gives UCI 3rd
Biological Passport Win at CAS, ASSOCIATED PRESS, Apr. 22, 2011, available at Factiva, Doc.
No. APRS000020110422e74m001s9 (internal quotation marks omitted).
194. Id.
195. Id.
196. Italian Rider De Bonis Loses Doping Ban Appeal, ASSOCIATED PRESS, June 22, 2011,
available at Factiva, Doc. No. APRS000020110622e76m001hv.
197. Id.
198. Connolly, supra note 17, at 197.
199. Over the past decade, there has been general agreement among CAS arbitrators that
CAS panels should typically follow the reasoning of previous panels. Id. Nevertheless, CAS
panels may diverge from prior reasoning in cases in which “there are compelling reasons in the
interest of justice” to do so. Id.
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IV. CONCERNS PRESENTED BY CYCLING’S BIOLOGICAL PASSPORT
Despite the CAS’s initial support for cycling’s biological
passport, serious questions persist as to the reliability of indirect
biological-passport evidence and the validity of its application in
antidoping cases. In turn, these uncertainties raise concerns over the
fundamental fairness of sanctioning cyclists for doping on the basis of
their biological passports alone. These unresolved issues should give
future CAS panels pause before those panels uphold doping
violations based solely on cycling’s biological passport.
A. Continuing Uncertainty Regarding Indirect Biological-Passport
Evidence
Debate persists over the reliability of indirect biological-passport
evidence and the clarity, consistency, and transparency of its
application in prosecuting cyclists for doping violations. This
uncertainty undermines the validity of using biological-passport
200
evidence as the sole basis for doping violations.
First, it is not clear that the biological passport provides reliable
evidence that a cyclist has committed a doping violation. Cycling’s
201
biological passport is based on a statistical model that analyzes
fluctuations in a cyclist’s biological variables and makes a threshold
determination as to whether that cyclist is likely to have committed a
202
doping violation. This analysis, however, is inherently uncertain.
203
The model can only point to a likelihood of doping —it cannot
204
definitively establish a doping violation. Moreover, the science

200. See Nafziger, supra note 67, at 47 (characterizing the “reliability of this approach” as
“highly controversial”).
201. See supra notes 131–133 and accompanying text.
202. The Athlete Biological Passport, supra note 132 (noting the “uncertainties associated
with the inferences that may be drawn from evidentiary values”).
203. Id. (“[T]he decision rule [under the biological passport] is not based on a true
probability of doping, but rather on how the profile differs from what is expected in clean
athletes. This conceptual difference is well known in forensics for the evaluation of scientific
evidence: to sentence an athlete solely from a high level of specificity would be a fallacy of
statistical reasoning that results from misunderstanding the idea of multiple testing. A high
number of anti-doping tests simply elevates the likelihood of finding a positive by pure chance
alone.” (internal quotation marks omitted)).
204. Ann Gripper, then-manager of the UCI’s Anti-Doping Service, explains that the
biological passport allows the UCI to “make a determination as to the likelihood of doping
based on that rider’s individual profile” but acknowledged that the Anti-Doping Service “may
not actually be able to say what it is, whether it’s autologous blood transfusions or micro-dosing
with EPO.” John Wilcockson, The New Passport: A Conversation with Anne Gripper,
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underlying the biological passport continues to be refined.
Questions remain regarding the statistical model’s ability to
accurately distinguish between biological fluctuations that should be
considered normal and those that may signal doping, especially
among the small and atypical population of elite professional
206
cyclists. The model may also be unable to differentiate between
fluctuations caused by doping and those that result from some other
207
cause, such as permitted altitude training or a cyclist’s preexisting
208
medical condition.
As a result, antidoping experts debate the reliability of
biological-passport evidence in signaling doping. Although the UCI
maintains that its statistical model is capable of determining a doping
violation “with a degree of certainty sufficient to commence
209
disciplinary proceedings,” others dissent. For instance, Dr. Max
VELONEWS (Oct. 24, 2007, 1:00 AM UTC), http://velonews.competitor.com/2007/10/news/thenew-passport-a-conversation-with-anne-gripper_13563 (quoting Gripper).
205. Bonnie D. Ford, Experts: Landis Info Could Be Crucial, ESPN, http://sports.espn.go
.com/oly/cycling/news/story?id=5222488 (last updated May 26, 2010, 9:19 PM ET) (reporting
that WADA Director General David Howman defended the biological passport but admitted
that refining was necessary).
206. The Athlete Biological Passport, supra note 132 (“Empirical evidence on a high number
of non-doped, control subjects is primordial since a high specificity—to avoid to falsely accuse
an innocent—is required in an anti-doping setting.”); Barry Ryan, Testa and BMC Weigh In
Behind Biological Passport, CYCLING NEWS (Mar. 2, 2011, 4:28 PM), http://www.cyclingnews
.com/news/testa-and-bmc-weigh-in-behind-biological-passport (“The main concern I have as a
physician is that the variation [of blood values] can be huge. We don’t know what the variability
is in this specific population [of professional cyclists], as they train a lot and travel a lot, so
maybe their variations are not exactly the same as those of average people. Most of the studies
[that antidoping authorities] use to support [cycling’s biological passport] are done on athletes,
but not athletes to this extreme level of fitness.” (quoting Dr. Max Testa) (internal quotation
marks omitted)).
207. The Athlete Biological Passport, supra note 132 (discussing “confounding factors” other
than doping that can cause fluctuations in an athlete’s biological passport and noting that
“transient exposure to altitude is known to modify markers of altered erythropoiesis” otherwise
thought to indicate blood doping); Explanation of Blood Passport, SCI. & INDUS. AGAINST
BLOOD DOPING, http://siab.org.au/what-is-blood-passport/passport-explanation.php (last visited
Oct. 7, 2011) (“What this threshold does not reveal, however, is whether the abnormal profile
was the result of doping, a medical condition or some other explanation. . . . [S]ome pathological
conditions give rise to highly unusual blood profiles.”).
208. See The Athlete Biological Passport, supra note 132 (“[D]oping is not the only possible
cause to explain a detected abnormality. A pathological condition must be excluded first. In
hematology for example, the prevalence of blood disorders may be high in certain
populations—typically a few percents—in function of factors such as age and ethnic origin.”).
209. UNION CYCLISTE INTERNATIONALE, supra note 12, at 19; see also Athlete’s Biological
Passport, LABORATOIRE SUISS D’ANALYSE DU DOPAGE, http://www.doping.chuv.ch/
en/lad_home/lad-recherche-developpement/lad-recherche-developpement-projets-finalises/ladrecherche-developpement-projets-finalises-pass-biol.htm (last updated Oct. 7, 2008) (“Thanks
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Testa, the BMC Racing Team doctor, believes that a “margin of
uncertainty” remains in biological-passport cases and has warned that
210
the program is still in the process of being refined. Similarly, Dr.
Roberto Corsetti, the Team Liquigas doctor, has argued that the
211
“variations in most cases . . . are debatable.” Others have gone even
further in their criticism. Dr. Nicolaas Faber and Dr. Bernard
Vandeginste have concluded that the model underlying cycling’s
biological passport is “clearly flawed,” “overly simplistic,” and
212
As a result, they assert that the “information
“misleading.”
gathered in the biological passport is grossly incomplete and,
therefore, prosecution on the basis of the biological passport lacks a
213
sound logical foundation.”
Second, serious concerns exist regarding the clarity, consistency,
214
and transparency of the expert review of biological-passport data.
Once the statistical computer model determines that fluctuations in a
cyclist’s biological passport are likely to signal a doping violation, that
cyclist’s data are submitted to a panel of three experts for further
215
interpretation. Although this expert review is supposed to address
216
the shortcomings of the statistical model,
the review process
presents problems of its own.

to a number of recent developments, it is possible today to obtain data with sufficient sensitivity
and specificity to launch disciplinary action in certain cases on the sole basis of indirect blood
markers.”).
210. Ryan, supra note 206.
211. Brown, supra note 166.
212. Nicolaas (Klaas) M. Faber & Bernard G.M. Vandeginste, Flawed Science ‘Legalized’ in
the Fight Against Doping: The Example of the Biological Passport, 15 ACCREDITATION &
QUALITY ASSURANCE 373, 373 (2010).
213. Id.; see also Klaas Faber & Marjan Sjerps, Anti-Doping Researchers Should Conform to
Certain Statistical Standards from Forensic Science, 49 SCI. & JUST. 214, 215 (2009) (“[A]ny
claim by the prosecution about the likelihood of the truth of a hypothesis lacks a sound logical
foundation.”).
214. Antidoping authorities should make an effort to apply their antidoping controls clearly,
consistently, and transparently. See Connolly, supra note 17, at 198 (“To continue to settle
doping cases fairly, CAS must ensure that all parties who come before its arbitration panels
trust in both the clarity of anti-doping rules and the consistency in their application.”).
215. UNION CYCLISTE INTERNATIONALE, supra note 12, at 20.
216. See The Athlete Biological Passport, supra note 132 (“The role of this panel of experts
is not only to protect the athlete’s right to a qualified review prior to the possible assertion of an
anti-doping rule violation, but it also ensures that all possible factors, causes and events are
considered thoroughly.”).
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For instance, few clear standards seem to guide the expert review
217
Instead, according to Dr. Michael
of biological-passport data.
Ashenden, a member of the UCI’s biological-passport panel, each
panel member has the discretion to “examine whatever markers he or
218
she chooses” in reviewing the data. Whereas objective standards
219
would ensure some degree of consistency, this subjective review is
220
likely to result in inconsistent outcomes.
Similarly troubling is the fact that only three of the nine panel
221
members review any given set of irregular biological-passport data.
Dr. Giuseppe D’Onofrio, another member of the UCI’s biologicalpassport panel, believes that this format may undermine the accuracy
222
Requiring all nine panel
and consistency of the data review.
members to examine biological-passport fluctuations would ensure a
223
more robust review of the data.

217. Antidoping authorities should strive for clarity and predictability in their antidoping
rules. Connolly, supra note 17, at 185 (“Regulations that may affect the careers of dedicated
athletes must be predictable.” (quoting USA Shooting & Q. v. Union Internationale de Tir, No.
CAS 94/129, at 1 (Ct. of Arb. for Sport 1995), http://jurisprudence.tas-cas.org/sites/
CaseLaw/Shared Documents/129.pdf)); Lambert, supra note 63, at 441 (advocating “greater
clarity of [antidoping] rules, consistency of enforcement, and predictability of adjudication”).
218. John Matson, Can Biological “Passports” Root Out Doping in Sports?, SCI. AM. (Mar.
5, 2009), http://www.scientificamerican.com/article.cfm?id=biological-passports-cycling-doping.
Although Dr. Ashenden “tend[s] to scrutinize reticulocyte [immature-red-blood-cell] values,”
id. (second alteration in original) (quoting Dr. Ashenden) (internal quotation mark omitted),
another expert might examine a different set of variables and come to a different conclusion.
219. Dr. Testa has acknowledged the subjective nature of this review. “To be honest, I like
to see some kind of fluctuations because that is the way it should be,” he explained. Ryan, supra
note 206 (quoting Dr. Testa) (internal quotation marks omitted). “The problem is how we
interpret the variation—is a stable number good or is it bad? Sometimes it’s better to see some
variation rather than someone always at the same number, because you can think that that is
also the result of manipulation. We’re just learning.” Id. (quoting Dr. Testa) (internal quotation
marks omitted).
220. Antidoping programs should promote consistency. Schmalzer, supra note 75, at 689
(“Inconsistencies and questionable behavior on the part of anti-doping organizations and
laboratories undermine the credibility of the anti-doping effort.”).
221. Ryan, supra note 1.
222. Dr. Giuseppe D’Onofrio said, “I don’t agree that it should be groups of only three
experts evaluating the profiles . . . . All nine of used [sic] should be involved together in order to
arrive at a broadly unanimous decision.” Id. (quoting Dr. D’Onofrio) (internal quotation marks
omitted).
223. According to Dr. Giuseppe Banfi, a hematological expert, “Involving all nine experts
on the panel would mean the procedures were sounder and more stable.” Id. (quoting Dr.
Banfi) (internal quotation marks omitted). Others have gone further. Federico Scaglia,
secretary of the Italian Professional Cyclists Association, has formally requested that “the UCI
no longer filter the selection of the athletes’ profiles and that all nine experts have the data of
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Furthermore, the review process lacks transparency. Because
the evaluation of biological-passport data requires a high level of
technological sophistication, this analysis has become “increasingly
225
black boxed” and closed to outside review. Dr. Giuseppe Banfi, a
hematological expert, has observed that “there is a closed attitude
from a scientific point of view as the [biological passport] system is
226
self-referential.” Although the UCI counsels cyclists and NGBs to
simply “trust the review that has been conducted by [the UCI’s]
227
experts,” this admonition provides little solace to cyclists accused of
doping solely on the basis of fluctuations in their biological
228
passports.
B. The Unfairness of Cycling’s Biological Passport
The unresolved questions regarding both biological-passport
data and the process by which these data are reviewed raise a related
set of concerns over the fairness of finding cyclists guilty of doping on
229
the basis of indirect biological-passport evidence alone.

the 850 riders involved and not just the anomalous data.” Id. (quoting Scaglia) (internal
quotation mark omitted).
224. Antidoping programs should foster transparency. Connolly, supra note 17, at 199 (“[I]t
is incumbent upon the sporting bodies to do everything in their power to promote a fair,
transparent, and trustworthy system.”).
225. Rayvon Fouché, Cycling’s “Fix,” 33 J. SPORT & SOC. ISSUES 97, 98 (2009) (“The
biological passport and the number of doping cases have moved the enforcement location of
clean athletic performance deeper into the scientific laboratory. The processes by which clean
performance is determined is getting increasingly black boxed by the technological
sophistication of the diagnostic tools and instruments and the breadth of scientific knowledge
required to interpret these samples, observations, and data.”).
226. Ryan, supra note 1.
227. Daniel Benson, Exclusive: Anne Gripper Breaks Silence on Blood Passport, CYCLING
NEWS (June 18, 2009, 10:42 AM), http://www.cyclingnews.com/features/exclusive-anne-gripperbreaks-silence-on-blood-passport (“What we’re expecting them to understand is that we have
the best experts in the world and that they’ve reviewed the data properly.” (quoting Anne
Gripper, then-manager of the UCI’s Anti-Doping Service) (internal quotation marks omitted)).
228. In response to questions regarding the transparency of cycling’s biological passport, at
least one cyclist has called for all biological-passport data to be made publicly available. Daniel
Benson, Wiggins Calls for Biological Passport Data To Be Made Public, CYCLING NEWS (Jan.
19, 2011, 10:53 AM), http://www.cyclingnews.com/news/wiggins-calls-for-biological-passportdata-to-be-made-public.
229. Considering this uncertainty, Dr. Testa has said, “I’m not sure if I would use the
[biological passport] parameters to say a guy is doing something . . . .” Ryan, supra note 206
(alteration in original) (quoting Dr. Testa) (internal quotation mark omitted).
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Antidoping policy requires a careful balancing of competing
230
goals. There is little doubt that “[d]oping is fundamentally contrary
231
Antidoping authorities serve a noble
to the spirit of sport.”
function, promoting “health, fairness and equality” by protecting the
232
rights of all athletes “to participate in doping-free sport.” The UCI
has taken important steps toward eliminating doping from
professional cycling, a sport often regarded by more cynical
233
commentators as “a competition between pills, not skills.”
At the same time, however, the need to effectively police sport
for doping must be weighed against the fundamental rights of
234
individual athletes. Although athletes agree to be bound by the
rules that govern their sports, antidoping authorities must apply these
rules fairly in light of all that is at stake for athletes accused of
235
doping. The mere allegation of doping can have a devastating
236
impact on an athlete. Finding an athlete guilty of doping can ruin

230. The CAS has recognized the “necessary balance” between the “needs of [antidoping
authorities] to implement new, reliable testing methods as quickly as possible, on the one hand,
and the interests of athletes and the sporting community in ensuring trustworthy test results, on
the other.” Int’l Ass’n of Athletics Fed’ns v. Fédération Royale Marocaine d’Athlétisme, No.
CAS 2003/A/452, at 1 (Ct. of Arb. for Sport 2003), http://jurisprudence.tas-cas.org/sites/
CaseLaw/Shared%20Documents/452.pdf.
231. WORLD ANTI-DOPING AGENCY, supra note 2, at 14.
232. Id. at 11.
233. James B. Jacobs & Bruce Samuels, The Drug Testing Project in International Sports:
Dilemmas in an Expanding Regulatory Scheme, 18 HASTINGS INT’L & COMP. L. REV. 557, 559
(1995).
234. See Weston, supra note 43, at 39 (“An athlete’s right to work in his or her chosen
profession, economic and liberty rights, and potential exposure to criminal charges in domestic
and foreign courts all are at stake in this process.” (footnote omitted)).
235. See U.S. Anti-Doping Agency v. Landis, No. 30 190 00847 06 (N. Am. Ct. of Arb. for
Sport 2007), at 5 (Campbell, J., dissenting), http://www.usada.org/files/active/arbitration_rulings/
Landis%20Final%20(20-09-07)%20(3).pdf (“[A]ny anti-doping system must be held
accountable, like the athletes. . . . Drug testing agencies should not be playing hide the ball when
athletes’ careers are on the line.”); Connolly, supra note 17, at 199 (“While the athletes must
recognize and adhere to this ethical responsibility, the sporting bodies must remain mindful of
the serious consequences that inevitably result from such a system.”); Foschi, supra note 60, at
458 (noting that a “prevalence of false positive tests” would “risk[] the careers and reputations
of innocent athletes”).
236. See Weston, supra note 43, at 7–8 (“The accusation alone converts the admired athlete
into an apparent pariah. The years an athlete spends focused on training, competing, and
working with coaches and teammates hardly prepares him or her for the complex process
involved in clearing his or her name, and taking on the system that could render the athlete
ineligible, banned from sport, and possibly subject to criminal liability.”).
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that athlete’s career: he may be banned from his sport, fined
237
enormous sums of money, and even subjected to criminal liability.
Therefore, antidoping authorities must “walk a fine line”
between pursuing means of eliminating doping from sport and
238
protecting the fundamental rights of individual athletes. In weighing
these competing interests, antidoping bodies confront difficult
239
challenges.
Never are these challenges greater than when
240
considering whether to implement a new antidoping technology.
Cutting-edge technologies offer great promise in the fight against
doping, but the science underlying such technologies must be
sufficiently refined to protect innocent athletes from false
241
These competing interests require a “delicate
accusations.
242
balance.”
Finding cyclists guilty of doping solely on the basis of their
biological passports threatens to upset this delicate balance. The
unresolved questions regarding the validity of cycling’s biological
passport and the critically important rights at stake for cyclists
243
counsel a cautious approach. Antidoping authorities should not
accuse athletes of doping unless “the possibility of a false positive is

237. Under cycling’s biological passport, “the mere inference of doping, created by a
deviation from the baseline, would be all that is required to ruin an athlete’s career.” Schmalzer,
supra note 75, at 698.
238. See id. at 677 (“Losing faith in either [of these goals] will undermine the very purpose
of drug testing, which is to protect the rights of athletes and maintain a sense of equality and
fairness in competition.”).
239. See Nafziger, supra note 67, at 55 (“The difficult question is: in the interest of a level
playing field for all athletes, to what extent should we run the risk of abandoning a traditional
reliance on hard laboratory data to justify the imposition of essentially penal sanctions against
athletes?”).
240. See Connolly, supra note 17, at 167–68 (“Despite the need to launch new methods as
quickly as possible in order to thwart cheaters, WADA and other organizations must not
prematurely introduce new testing methods. They must [instead] exercise caution before
approving a testing method because of the potentially devastating consequences to the image of
anti-doping programs in general if an athlete were to be prosecuted on the basis of a false
positive test resulting from an unreliable method.”).
241. Id. at 169 (“The sporting world has a significant interest in implementing new testing
techniques that will discourage the use of performance-enhancing substances and expose
cheaters as quickly as possible. But sport also has an interest in making sure that the reliability
of these testing methods is unquestionable.”).
242. Id.
243. See Foschi, supra note 60, at 485 (“[G]reat precaution must be taken to ensure that the
desire to rid the sport of cheaters does not carelessly allow innocent athletes to bear the same
label without the same fault.”).
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244

virtually nonexistent.” Before aggressively pursuing future doping
sanctions on the basis of indirect biological-passport evidence, the
UCI would be wise to reassess whether such efforts adequately
balance the interest in eliminating doping from sport against the
fundamental rights of individual cyclists. Failing to balance these
equally important goals may serve to undermine—rather than
245
bolster—the integrity of the sport.
V. RECOMMENDATIONS FOR IMPROVING CYCLING’S BIOLOGICAL
PASSPORT
Despite these concerns, there are a number of less problematic
ways in which antidoping authorities can use cycling’s biological
passport as an effective antidoping control. First, the UCI should use
the biological passport primarily as a basis for instituting intelligent,
targeted testing against cyclists who exhibit irregularities in their
biological-passport variables. Second, WADA and the CAS should
make the standard of proof more stringent in cases in which
allegations of doping rest solely on indirect biological-passport
evidence. Each of these alternatives would effectively ameliorate the
existing flaws in cycling’s biological passport.
A. Using Cycling’s Biological Passport for Targeted Testing
The UCI should use cycling’s biological passport primarily as a
basis for instituting intelligent, targeted testing against cyclists with
irregular fluctuations in their biological-passport profiles, rather than
pursuing doping violations on the basis of those cyclists’ biological246
passport data alone. In other words, the UCI should utilize indirect
biological-passport evidence in tandem with proven antidoping
247
controls, such as direct detection of prohibited substances. When

244. Connolly, supra note 17, at 169.
245. See Foschi, supra note 60, at 476 (noting that overly aggressive antidoping policy may
be “offensive to the very spirit of the sport that WADA and the Olympic Movement seek to
develop and protect”).
246. See UCI Anti-Doping Programme, supra note 46 (describing the ways in which the UCI
already employs targeted testing in its antidoping efforts).
247. According to Dr. Neil Robinson, indirect biological-passport evidence helps antidoping
authorities to “predict when [certain cyclists are] going to dope, and that allows [them] to
provide information to the [UCI] so [it] can better adapt [its] anti-doping tests” to target cyclists
with irregularities in their biological-passport profiles. Biological Passport: 10 Years Beyond
Other Sports, BIKE RADAR (Mar. 9, 2009, 8:44 PM GMT), http://www.bikeradar.com/
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irregularities in an individual cyclist’s biological passport suggest the
effects of doping, the UCI should target that cyclist for additional
testing. If this targeted testing results in an analytical positive finding,
the UCI should then pursue doping sanctions on the basis of the
positive doping test.
This approach would offer a number of advantages. First,
targeted testing would largely eliminate concerns about the reliability
of indirect biological-passport evidence and would provide cyclists
with greater safeguards against false positives. Under this approach,
doping sanctions would be supported by analytical positive findings in
248
addition to biological-passport data. Second, targeted testing would
enable the UCI to build a greater body of scientific research linking
indirect biological-passport data with analytical positive findings,
perhaps laying the foundation for a more robust and scientifically
249
sound biological passport in the future. Third, this approach would
allow the UCI to avail itself of the strict-liability standard applicable
in conventional analytical positive cases. As a result, the UCI might
avoid the lengthy and expensive arbitration proceedings that typically
result when the UCI pursues controversial nonanalytical positive
cases without the benefit of strict liability. Fourth, targeted testing
would continue to deter cyclists from doping without subjecting them
250
to potentially unfair sanctions.
In fact, targeted testing appears to have been the primary
approach envisioned by WADA. In its Athlete Biological Passport
Operating Guidelines, WADA describes the biological passport as a

news/article/biological-passport-10-years-beyond-other-sports-20764 (quoting Dr. Robinson)
(internal quotation mark omitted).
248. According to Dr. Testa, “[Biological-passport] parameters . . . would make me focus
more on the athlete and do more controls on him . . . . [Direct and indirect testing] have to work
together.” Ryan, supra note 206 (quoting Dr. Testa) (internal quotation marks omitted).
249. Increased data would “improve scientific understanding of the range of [biologicalpassport] readings that are normal.” Gilbert, supra note 80, at 19. According to Dr. Don Catlin,
former director of the UCLA Olympic Analytical Laboratory, “To really reduce false negatives,
you’ve got to have a lot of data on a lot of people to know where to draw the line . . . . We’re not
there yet.” Id. (quoting Dr. Catlin) (internal quotation marks omitted).
250. There are, of course, potential disadvantages to targeted testing. For instance, cyclists
might be concerned that antidoping authorities would abuse this approach by harassing
individual cyclists with excessive testing. Nevertheless, cyclists’ rights are better safeguarded
under targeted testing than under a policy of pursuing doping violations based on indirect
biological-passport evidence alone. Second, the UCI may be concerned that this approach
would make it more difficult to pursue doping violations in the absence of a positive analytical
finding, which could result in increased false negatives.
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“complementary strategy” to traditional antidoping protocols.
WADA states that “[t]he objective of the Athlete Biological Passport
is to monitor and identify possible doping in order to intelligently
target an Athlete for traditional Doping Controls and where
252
appropriate to establish a doping violation.” This language indicates
that indirect biological-passport evidence should be used primarily as
a complementary tool, rather than serving as the sole basis for
proving doping violations.
Moreover, the UCI has already successfully implemented
intelligent, targeted testing based on indirect biological-passport
evidence. This approach has proven effective in a number of cases,
resulting in analytical positive findings and allowing the UCI to
253
prosecute cyclists for doping based on positive doping tests.
Furthermore, in December 2010, the UCI announced plans to
254
increase targeted testing under its biological-passport program.
Nevertheless, the UCI has also continued to pursue controversial
nonanalytical positive cases on the basis of indirect biologicalpassport evidence alone. In fact, in a report following the 2010 Tour
255
de France, WADA drew “stark attention” to the fact that the UCI’s

251. WORLD ANTI-DOPING AGENCY, supra note 57, at 3. Though these guidelines are not
mandatory, they reflect WADA’s position as to the most effective way of administering a
biological-passport program. Id. at 4.
252. Id. at 10 (emphasis added) (emphasis omitted).
253. See, e.g., Press Release, Union Cycliste Internationale, Manuel Vazquez Hueso
Provisionally Suspended (Apr. 26, 2010), available at http://www.uci.ch/Modules/ENews/ENews
Details.asp?id=Njg0NQ (“The decision to provisionally suspend this rider was made in response
to . . . an Adverse Analytical Finding of EPO in a urine sample . . . . This targeted test was
carried out on the basis of information contained in the rider’s biological passport.”); Press
Release, Union Cycliste Internationale, Massimo Giunti Provisionally Suspended (Mar. 10,
2010), available at http://www.uci.ch/Modules/ENews/ENewsDetails.asp?id=Njc3Mw (“This
adverse finding was a direct result of a targeted urine test conducted because of an unusual
blood profile in Mr. Giunti’s biological passport.”); Press Release, Union Cycliste
Internationale, Pawel and Kacper Szczepaniak Provisionally Suspended (Mar. 11, 2010),
available at http://www.uci.ch/Modules/ENews/ENewsDetails.asp?id=Njc3NA (“These adverse
findings were a direct result of a targeted urine test . . . . The blood samples collected before the
event . . . had already shown, within the biological passport programme, that the blood profiles
of these two riders were suspect.”).
254. Press Release, Union Cycliste Internationale, The UCI Presents the Main Themes of
Its Anti-Doping Programme for 2011 (Dec. 3, 2010), available at http://www.uci.ch/Modules/
ENews/ENewsDetails.asp?id=NzE1Ng (announcing that the UCI’s 2011 antidoping efforts
would “provide[] for a significant increase in the number of controls conducted on riders whose
[biological-passport] profiles may indicate illegal behaviour”).
255. INDEP. OBSERVER TEAM, REPORT OF THE INDEPENDENT OBSERVERS: TOUR DE
FRANCE 2010 (2010), available at http://www.wada-ama.org/Documents/World_Anti-Doping_
Program/WADP-Independent-Observer/WADA_IO_Report_TDF2010_EN.pdf.
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biological passport was “not being backed up with dedicated and
256
targeted anti-doping controls.” Instead, WADA criticized the UCI
for continuing to prioritize analysis of indirect biological-passport
257
data “to the detriment of [directly] testing for banned substances.”
In the future, the UCI should consider utilizing the biological
passport primarily as a tool for instituting targeted testing, rather than
pursuing doping violations on the basis of biological-passport data
alone.
B. Imposing a Heightened Standard of Proof in Biological-Passport
Cases
Alternatively, if the UCI continues to pursue doping violations
based solely on indirect biological-passport evidence, the UCI should
be required to prove such violations under a heightened standard of
proof. As written, the Code requires antidoping authorities to prove
doping violations only to the “comfortable satisfaction” of the
258
hearing panel.
This intermediate standard of proof has been
criticized in light of the quasi-criminal, penal nature of antidoping
259
cases. The standard of proof applied in analytical positive cases may
be less important, as athletes in such cases are held strictly liable for
260
positive doping tests. In nonanalytical positive cases, however, the
261
standard of proof applied can be a determining factor. In light of
the continuing uncertainty surrounding biological-passport evidence,

256. Ryan, supra note 206.
257. Barry Ryan, UCI To Study Recommendations of WADA’s Independent Tour de France
Report, CYCLING NEWS (Oct. 29, 2010, 4:15 PM), http://www.cyclingnews.com/news/uci-tostudy-recommendations-of-wadas-independent-tour-de-france-report. Several cyclists with
suspicious biological-passport profiles and impressive Tour performances were not even directly
tested. For instance, one cyclist with a “priority index” of ten—meaning that he was considered
to be under the highest suspicion of doping—was not required to give any blood or urine
samples between April 3, 2010 and the beginning of the Tour, nor was he required to give any
blood samples after the Tour had started. Id.
258. WORLD ANTI-DOPING AGENCY, supra note 2, at 26. This standard is “greater than a
mere balance of probability but less than proof beyond a reasonable doubt.” Id.
259. See Nafziger, supra note 67, at 54 (“[T]he consequences of a doping infraction are
essentially of a penal nature and therefore merit a high standard of proof.”); Straubel, supra
note 18, at 1272 (“[T]he burden of proof used in doping cases should be more like that used in
criminal cases.”); Weston, supra note 43, at 44 (“The quasi-criminal nature of doping hearings
and sanctions warrants a process that comports with the principles underlying Constitutional
protections for defendants in criminal cases.”).
260. See Greene, supra note 68, at 157 (discussing the relatively “straightforward evidentiary
issues” presented in analytical positive cases under the strict-liability standard).
261. McLaren, supra note 84, at 194–95.
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an intermediate standard of proof provides insufficient safeguards for
262
cyclists accused of doping on the basis of indirect evidence alone.
Instead, WADA and the CAS should consider requiring the UCI
to prove doping violations in biological-passport cases beyond a
263
reasonable doubt. WADA could amend the Code to mandate the
beyond-a-reasonable-doubt standard in biological-passport cases, or
the CAS could choose to apply this heightened standard in appeals of
264
such cases. The beyond-a-reasonable-doubt standard would provide
more robust protections for cyclists accused of doping on the basis of
fluctuations in their biological passports and would better guarantee
265
that innocent cyclists are not wrongly found guilty of doping.
Though a heightened standard would make biological-passport cases
more difficult to prove, such a standard would also serve antidoping
authorities’ interests by conferring greater legitimacy on those
266
decisions that do find cyclists guilty of doping. Adopting the
beyond-a-reasonable-doubt standard in these cases would largely
eliminate the various concerns with the existing approach while
allowing the UCI to continue to pursue doping violations on the basis
of indirect biological-passport evidence.
CONCLUSION
The biological passport has the potential to be a valuable
weapon in the fight against doping in sport. Buoyed by its initial
biological-passport successes before the CAS, the UCI will no doubt
continue to aggressively pursue doping sanctions against cyclists

262. See Myler, supra note 86, at 750 (describing the comfortable-satisfaction standard as
“ambiguous”); Nafziger, supra note 67, at 54 (describing critiques that the standard is “too
relaxed to protect athletes’ rights of due process”).
263. See Greene, supra note 68, at 166 (“CAS Tribunals should consider adopting a criminal
burden of proof in non-analytical positive cases because evidence of an athlete’s guilt in these
matters is not [as] straightforward as it is in doping cases that involve an analytical positive.”);
McLaren, supra note 84, at 211 (observing that the comfortable-satisfaction standard in
nonanalytical positive cases “continues to depend on the gravity of the case and that
comfortable satisfaction moves to a very high standard that can become indistinguishable from
beyond a reasonable doubt”).
264. See Straubel, supra note 18, at 1266 (“While the [comfortable-satisfaction] standard has
been codified in the World Anti-Doping Code, it was CAS that developed the standard and it
will be CAS that will refine the standard.”).
265. Paul Greene, Can the Biological Passport Program Be Trusted?, PRETI SPORTS L.
BLOG (Aug. 20, 2010, 2:58 PM), http://pretisportslaw.blogspot.com/2010/08/can-biologicalpassport-program-be.html.
266. Id.
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solely on the basis of indirect biological-passport evidence.
Meanwhile, WADA has adopted uniform biological-passport
guidelines, and antidoping bodies in other sports have begun to
267
implement biological passports of their own.
Nevertheless, antidoping authorities must proceed carefully. The
biological passport represents a paradigm shift in antidoping efforts,
and it is still being refined. The initial cases pursued through cycling’s
biological passport have raised serious concerns about the reliability
of inferences drawn from biological-passport data and the fairness of
finding an athlete guilty of doping on the basis of indirect evidence
alone. These concerns should give future CAS panels pause before
they continue to uphold doping sanctions based solely on indirect
biological-passport evidence. The biological passport promises a
valuable approach to antidoping efforts, but “maybe it’s been put on
268
the road too soon to act as an anti-doping control.”

267. For example, the International Association of Athletics Federations, the international
body that governs the sport of track and field, adopted a biological-passport program in
December 2010. Press Release, Int’l Ass’n of Athletics Fed’ns, Athlete Biological Passport: A
Promising New Strategy in the Fight Against Doping in Athletics (Dec. 14, 2010), available at
http://www.iaaf.org/antidoping/news/newsid=58918.html.
268. Ryan, supra note 1 (quoting Dr. Corsetti) (internal quotation mark omitted).

